|
-23.0
|
AAP
|
Advance Auto Parts Inc.
|
42.76
|
hold
|
0%
/
1%
|
19%
|
31.2
↑
|
-1.05
|
-0.23
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Auto Parts |
| Market Cap |
2,588,123,136 |
Cash |
3,120,000,000 |
| Debt |
5,628,000,256 |
Recommendation |
hold |
| RSI |
31.2 |
MACD |
-3.72 |
| Signal |
-2.67 |
Histogram |
-1.05 |
| Revenue Growth |
0.0% |
EPS Growth |
260.0% |
| Gross Margin |
45.0% |
ROE |
5.0% |
| Target Price |
50.21 |
Analysts |
19 |
|
|
7.0
|
ABEO
|
Abeona Therapeutics Inc.
|
5.98
|
strong_buy
|
2,745%
/
-246%
|
55%
|
43.1
↑
|
-0.06
|
0.07
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
338,529,376 |
Cash |
146,826,000 |
| Debt |
19,872,000 |
Recommendation |
strong_buy |
| RSI |
43.1 |
MACD |
-0.15 |
| Signal |
-0.09 |
Histogram |
-0.06 |
| Revenue Growth |
2,745.0% |
EPS Growth |
N/A |
| Gross Margin |
-40.0% |
ROE |
-43.0% |
| Target Price |
18.86 |
Analysts |
7 |
|
|
6.0
|
ACGL
|
Arch Capital Group Ltd.
|
98.61
|
buy
|
-10%
/
24%
|
64%
|
47.0
↑
|
-0.08
|
0.06
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Diversified |
| Market Cap |
33,727,084,544 |
Cash |
4,464,000,000 |
| Debt |
4,286,000,128 |
Recommendation |
buy |
| RSI |
47.0 |
MACD |
-0.12 |
| Signal |
-0.04 |
Histogram |
-0.08 |
| Revenue Growth |
-10.0% |
EPS Growth |
-7.0% |
| Gross Margin |
39.0% |
ROE |
20.0% |
| Target Price |
111.87 |
Analysts |
19 |
|
|
30.0
|
ACHC
|
Acadia Healthcare Company, Inc.
|
28.25
|
buy
|
0%
/
-33%
|
69%
|
44.6
↑
|
-0.12
|
0.30
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
2,658,012,672 |
Cash |
171,290,000 |
| Debt |
2,587,631,104 |
Recommendation |
buy |
| RSI |
44.6 |
MACD |
-0.55 |
| Signal |
-0.43 |
Histogram |
-0.12 |
| Revenue Growth |
0.0% |
EPS Growth |
-64.0% |
| Gross Margin |
41.0% |
ROE |
-41.0% |
| Target Price |
33.39 |
Analysts |
14 |
|
|
-25.0
|
ACI
|
Albertsons Companies, Inc.
|
12.46
|
hold
|
0%
/
0%
|
18%
|
49.7
↑
|
0.09
|
-0.25
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Grocery Stores |
| Market Cap |
6,081,131,008 |
Cash |
307,900,000 |
| Debt |
15,701,000,192 |
Recommendation |
hold |
| RSI |
49.7 |
MACD |
-0.11 |
| Signal |
-0.20 |
Histogram |
0.09 |
| Revenue Growth |
0.0% |
EPS Growth |
-58.0% |
| Gross Margin |
27.0% |
ROE |
3.0% |
| Target Price |
14.19 |
Analysts |
16 |
|
|
13.0
|
ACTG
|
Acacia Research Corporation
|
4.52
|
none
|
124%
/
-5%
|
68%
|
47.0
↑
|
-0.01
|
0.13
|
▼ |
| Sector |
Industrials |
Industry |
Business Equipment & Supplies |
| Market Cap |
436,213,024 |
Cash |
332,569,984 |
| Debt |
102,038,000 |
Recommendation |
none |
| RSI |
47.0 |
MACD |
-0.03 |
| Signal |
-0.02 |
Histogram |
-0.01 |
| Revenue Growth |
124.0% |
EPS Growth |
N/A |
| Gross Margin |
22.0% |
ROE |
-4.0% |
| Target Price |
6.00 |
Analysts |
1 |
|
|
-1.0
|
ADC
|
Agree Realty Corporation
|
72.50
|
buy
|
17%
/
29%
|
36%
|
33.2
↑
|
-0.17
|
-0.01
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
9,130,010,624 |
Cash |
32,217,000 |
| Debt |
3,845,841,920 |
Recommendation |
buy |
| RSI |
33.2 |
MACD |
-1.09 |
| Signal |
-0.92 |
Histogram |
-0.17 |
| Revenue Growth |
17.0% |
EPS Growth |
2.0% |
| Gross Margin |
88.0% |
ROE |
4.0% |
| Target Price |
84.86 |
Analysts |
18 |
|
|
2.0
|
AEE
|
Ameren Corporation
|
106.09
|
buy
|
-6%
/
19%
|
45%
|
38.8
↑
|
-0.17
|
0.02
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
29,378,607,104 |
Cash |
12,000,000 |
| Debt |
21,808,001,024 |
Recommendation |
buy |
| RSI |
38.8 |
MACD |
-1.08 |
| Signal |
-0.91 |
Histogram |
-0.17 |
| Revenue Growth |
-6.0% |
EPS Growth |
12.0% |
| Gross Margin |
52.0% |
ROE |
12.0% |
| Target Price |
120.40 |
Analysts |
15 |
|
|
-26.0
|
AKBA
|
Akebia Therapeutics, Inc.
|
0.94
|
buy
|
-21%
/
-14%
|
5%
|
45.0
↑
|
0.01
|
-0.26
|
▼ |
| Sector |
Healthcare |
Industry |
Drug Manufacturers - Specialty & Generic |
| Market Cap |
243,465,536 |
Cash |
155,548,000 |
| Debt |
199,188,000 |
Recommendation |
buy |
| RSI |
45.0 |
MACD |
-0.06 |
| Signal |
-0.08 |
Histogram |
0.01 |
| Revenue Growth |
-21.0% |
EPS Growth |
N/A |
| Gross Margin |
81.0% |
ROE |
-109.0% |
| Target Price |
3.80 |
Analysts |
5 |
|
|
-48.0
|
ALDX
|
Aldeyra Therapeutics, Inc.
|
1.49
|
strong_buy
|
N/A
/
0%
|
5%
|
41.1
↑
|
0.01
|
-0.48
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
89,584,736 |
Cash |
45,089,784 |
| Debt |
143,447 |
Recommendation |
strong_buy |
| RSI |
41.1 |
MACD |
-0.05 |
| Signal |
-0.06 |
Histogram |
0.01 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-49.0% |
| Target Price |
6.60 |
Analysts |
5 |
|
|
-14.0
|
ALHC
|
Alignment Healthcare, Inc.
|
13.59
|
strong_buy
|
32%
/
1%
|
7%
|
39.0
↑
|
0.28
|
-0.14
|
▼ |
| Sector |
Healthcare |
Industry |
Healthcare Plans |
| Market Cap |
2,825,266,688 |
Cash |
701,710,976 |
| Debt |
330,500,000 |
Recommendation |
strong_buy |
| RSI |
39.0 |
MACD |
-1.09 |
| Signal |
-1.37 |
Histogram |
0.28 |
| Revenue Growth |
32.0% |
EPS Growth |
143.0% |
| Gross Margin |
13.0% |
ROE |
20.0% |
| Target Price |
24.08 |
Analysts |
13 |
|
|
39.0
|
ALKS
|
Alkermes plc
|
47.20
|
none
|
27%
/
4%
|
72%
|
39.5
↑
|
-0.21
|
0.39
|
▼ |
| Sector |
Healthcare |
Industry |
Drug Manufacturers - Specialty & Generic |
| Market Cap |
7,953,656,320 |
Cash |
656,577,024 |
| Debt |
1,572,563,968 |
Recommendation |
none |
| RSI |
39.5 |
MACD |
-0.57 |
| Signal |
-0.36 |
Histogram |
-0.21 |
| Revenue Growth |
27.0% |
EPS Growth |
-99.0% |
| Gross Margin |
87.0% |
ROE |
4.0% |
| Target Price |
56.00 |
Analysts |
17 |
|
|
24.0
|
ALL
|
Allstate Corporation (The)
|
257.87
|
hold
|
12%
/
19%
|
80%
|
49.9
↑
|
-1.05
|
0.24
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Property & Casualty |
| Market Cap |
65,889,722,368 |
Cash |
5,714,999,808 |
| Debt |
7,496,999,936 |
Recommendation |
hold |
| RSI |
49.9 |
MACD |
0.78 |
| Signal |
1.82 |
Histogram |
-1.05 |
| Revenue Growth |
12.0% |
EPS Growth |
61.0% |
| Gross Margin |
37.0% |
ROE |
46.0% |
| Target Price |
274.09 |
Analysts |
22 |
|
|
6.0
|
AMH
|
American Homes 4 Rent
|
33.42
|
buy
|
3%
/
26%
|
82%
|
43.7
↑
|
-0.13
|
0.06
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Residential |
| Market Cap |
13,749,790,720 |
Cash |
83,670,000 |
| Debt |
5,149,175,808 |
Recommendation |
buy |
| RSI |
43.7 |
MACD |
0.01 |
| Signal |
0.14 |
Histogram |
-0.13 |
| Revenue Growth |
3.0% |
EPS Growth |
11.0% |
| Gross Margin |
57.0% |
ROE |
7.0% |
| Target Price |
37.16 |
Analysts |
22 |
|
|
-29.0
|
AMRC
|
Ameresco, Inc.
|
22.60
|
buy
|
9%
/
1%
|
17%
|
44.8
↑
|
-0.28
|
-0.29
|
▼ |
| Sector |
Industrials |
Industry |
Engineering & Construction |
| Market Cap |
1,166,925,952 |
Cash |
138,332,992 |
| Debt |
2,569,072,896 |
Recommendation |
buy |
| RSI |
44.8 |
MACD |
-0.71 |
| Signal |
-0.43 |
Histogram |
-0.28 |
| Revenue Growth |
9.0% |
EPS Growth |
-25.0% |
| Gross Margin |
16.0% |
ROE |
4.0% |
| Target Price |
43.50 |
Analysts |
10 |
|
|
46.0
|
AMRX
|
Amneal Pharmaceuticals, Inc.
|
17.68
|
buy
|
10%
/
5%
|
85%
|
48.2
↑
|
-0.09
|
0.46
|
▼ |
| Sector |
Healthcare |
Industry |
Drug Manufacturers - Specialty & Generic |
| Market Cap |
6,109,112,832 |
Cash |
131,413,000 |
| Debt |
2,791,760,896 |
Recommendation |
buy |
| RSI |
48.2 |
MACD |
0.04 |
| Signal |
0.13 |
Histogram |
-0.09 |
| Revenue Growth |
10.0% |
EPS Growth |
157.0% |
| Gross Margin |
40.0% |
ROE |
613.0% |
| Target Price |
21.00 |
Analysts |
5 |
|
|
17.0
|
ANDE
|
The Andersons, Inc.
|
67.26
|
none
|
-1%
/
2%
|
68%
|
48.0
↑
|
0.06
|
0.17
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Food Distribution |
| Market Cap |
2,193,462,528 |
Cash |
66,549,000 |
| Debt |
900,764,992 |
Recommendation |
none |
| RSI |
48.0 |
MACD |
-1.50 |
| Signal |
-1.56 |
Histogram |
0.06 |
| Revenue Growth |
-1.0% |
EPS Growth |
618.0% |
| Gross Margin |
7.0% |
ROE |
12.0% |
| Target Price |
88.33 |
Analysts |
3 |
|
|
-46.0
|
ANGI
|
Angi Inc.
|
4.66
|
none
|
-11%
/
-22%
|
2%
|
42.7
↑
|
0.03
|
-0.46
|
▼ |
| Sector |
Communication Services |
Industry |
Internet Content & Information |
| Market Cap |
204,403,504 |
Cash |
188,700,992 |
| Debt |
422,350,016 |
Recommendation |
none |
| RSI |
42.7 |
MACD |
-0.22 |
| Signal |
-0.25 |
Histogram |
0.03 |
| Revenue Growth |
-11.0% |
EPS Growth |
N/A |
| Gross Margin |
96.0% |
ROE |
-26.0% |
| Target Price |
8.00 |
Analysts |
5 |
|
|
11.0
|
APEI
|
American Public Education, Inc.
|
45.85
|
none
|
6%
/
7%
|
50%
|
42.0
↑
|
0.24
|
0.11
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Education & Training Services |
| Market Cap |
842,054,016 |
Cash |
221,604,000 |
| Debt |
153,467,008 |
Recommendation |
none |
| RSI |
42.0 |
MACD |
-1.34 |
| Signal |
-1.58 |
Histogram |
0.24 |
| Revenue Growth |
6.0% |
EPS Growth |
N/A |
| Gross Margin |
56.0% |
ROE |
16.0% |
| Target Price |
62.83 |
Analysts |
6 |
|
|
-39.0
|
APTV
|
Aptiv PLC
|
44.85
|
buy
|
2%
/
1%
|
0%
|
30.9
↑
|
-0.04
|
-0.39
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Auto Parts |
| Market Cap |
9,499,225,088 |
Cash |
761,000,000 |
| Debt |
5,683,999,744 |
Recommendation |
buy |
| RSI |
30.9 |
MACD |
-2.72 |
| Signal |
-2.68 |
Histogram |
-0.04 |
| Revenue Growth |
2.0% |
EPS Growth |
-35.0% |
| Gross Margin |
19.0% |
ROE |
5.0% |
| Target Price |
66.61 |
Analysts |
18 |
|
|
-3.0
|
ARL
|
American Realty Investors, Inc.
|
15.05
|
none
|
9%
/
16%
|
19%
|
44.8
↑
|
0.07
|
-0.03
|
▼ |
| Sector |
Real Estate |
Industry |
Real Estate Services |
| Market Cap |
N/A |
Cash |
10,849,000 |
| Debt |
218,028,000 |
Recommendation |
none |
| RSI |
44.8 |
MACD |
-0.27 |
| Signal |
-0.34 |
Histogram |
0.07 |
| Revenue Growth |
9.0% |
EPS Growth |
N/A |
| Gross Margin |
40.0% |
ROE |
1.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
29.0
|
ARMK
|
Aramark
|
56.62
|
strong_buy
|
9%
/
2%
|
79%
|
41.6
↑
|
-0.48
|
0.29
|
▼ |
| Sector |
Industrials |
Industry |
Specialty Business Services |
| Market Cap |
15,337,704,448 |
Cash |
520,393,984 |
| Debt |
6,468,355,072 |
Recommendation |
strong_buy |
| RSI |
41.6 |
MACD |
0.24 |
| Signal |
0.72 |
Histogram |
-0.48 |
| Revenue Growth |
9.0% |
EPS Growth |
33.0% |
| Gross Margin |
15.0% |
ROE |
12.0% |
| Target Price |
67.97 |
Analysts |
16 |
|
|
9.0
|
AROC
|
Archrock, Inc.
|
31.69
|
strong_buy
|
-3%
/
22%
|
48%
|
38.4
↑
|
-0.02
|
0.09
|
▼ |
| Sector |
Energy |
Industry |
Oil & Gas Equipment & Services |
| Market Cap |
5,477,564,928 |
Cash |
2,000,000 |
| Debt |
2,357,209,088 |
Recommendation |
strong_buy |
| RSI |
38.4 |
MACD |
-1.14 |
| Signal |
-1.12 |
Histogram |
-0.02 |
| Revenue Growth |
-3.0% |
EPS Growth |
6.0% |
| Gross Margin |
67.0% |
ROE |
22.0% |
| Target Price |
42.50 |
Analysts |
8 |
|
|
37.0
|
ARW
|
Arrow Electronics, Inc.
|
205.98
|
none
|
32%
/
2%
|
78%
|
46.9
↑
|
-0.53
|
0.37
|
▼ |
| Sector |
Technology |
Industry |
Electronics & Computer Distribution |
| Market Cap |
10,380,634,112 |
Cash |
244,631,008 |
| Debt |
2,170,579,968 |
Recommendation |
none |
| RSI |
46.9 |
MACD |
-1.81 |
| Signal |
-1.28 |
Histogram |
-0.53 |
| Revenue Growth |
32.0% |
EPS Growth |
46.0% |
| Gross Margin |
11.0% |
ROE |
12.0% |
| Target Price |
235.00 |
Analysts |
4 |
|
|
58.0
|
ARWR
|
Arrowhead Pharmaceuticals, Inc.
|
82.74
|
none
|
171%
/
-48%
|
89%
|
43.3
↑
|
-0.81
|
0.58
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
11,993,917,440 |
Cash |
1,597,859,968 |
| Debt |
1,379,405,056 |
Recommendation |
none |
| RSI |
43.3 |
MACD |
0.56 |
| Signal |
1.38 |
Histogram |
-0.81 |
| Revenue Growth |
171.0% |
EPS Growth |
N/A |
| Gross Margin |
100.0% |
ROE |
-55.0% |
| Target Price |
110.18 |
Analysts |
11 |
|
|
29.0
|
ASTH
|
Astrana Health Inc.
|
38.60
|
strong_buy
|
48%
/
1%
|
65%
|
49.3
↑
|
0.23
|
0.29
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
1,882,981,760 |
Cash |
400,792,000 |
| Debt |
979,411,008 |
Recommendation |
strong_buy |
| RSI |
49.3 |
MACD |
-0.37 |
| Signal |
-0.60 |
Histogram |
0.23 |
| Revenue Growth |
48.0% |
EPS Growth |
110.0% |
| Gross Margin |
10.0% |
ROE |
7.0% |
| Target Price |
51.50 |
Analysts |
8 |
|
|
-1.0
|
ATO
|
Atmos Energy Corporation
|
167.70
|
hold
|
5%
/
28%
|
29%
|
44.0
↑
|
-0.02
|
-0.01
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Gas |
| Market Cap |
28,161,941,504 |
Cash |
520,952,992 |
| Debt |
10,323,866,624 |
Recommendation |
hold |
| RSI |
44.0 |
MACD |
-1.50 |
| Signal |
-1.48 |
Histogram |
-0.02 |
| Revenue Growth |
5.0% |
EPS Growth |
23.0% |
| Gross Margin |
62.0% |
ROE |
10.0% |
| Target Price |
188.18 |
Analysts |
11 |
|
|
12.0
|
AURA
|
Aura Biosciences, Inc.
|
7.43
|
none
|
N/A
/
0%
|
63%
|
47.9
↑
|
-0.07
|
0.12
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
767,415,616 |
Cash |
323,840,000 |
| Debt |
16,594,000 |
Recommendation |
none |
| RSI |
47.9 |
MACD |
0.08 |
| Signal |
0.16 |
Histogram |
-0.07 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-53.0% |
| Target Price |
16.60 |
Analysts |
5 |
|
|
-2.0
|
AVA
|
Avista Corporation
|
37.64
|
none
|
0%
/
12%
|
47%
|
39.8
↑
|
0.01
|
-0.02
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Diversified |
| Market Cap |
3,154,131,712 |
Cash |
25,000,000 |
| Debt |
3,376,999,936 |
Recommendation |
none |
| RSI |
39.8 |
MACD |
-0.62 |
| Signal |
-0.63 |
Histogram |
0.01 |
| Revenue Growth |
0.0% |
EPS Growth |
148.0% |
| Gross Margin |
67.0% |
ROE |
8.0% |
| Target Price |
41.33 |
Analysts |
6 |
|
|
23.0
|
AVBP
|
ArriVent BioPharma, Inc.
|
30.15
|
strong_buy
|
N/A
/
0%
|
74%
|
48.3
↑
|
0.11
|
0.23
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
1,487,614,208 |
Cash |
373,119,008 |
| Debt |
351,000 |
Recommendation |
strong_buy |
| RSI |
48.3 |
MACD |
-0.22 |
| Signal |
-0.33 |
Histogram |
0.11 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-53.0% |
| Target Price |
44.70 |
Analysts |
10 |
|
|
-36.0
|
AVD
|
American Vanguard Corporation
|
2.29
|
none
|
-10%
/
-11%
|
6%
|
47.9
↑
|
0.02
|
-0.36
|
▼ |
| Sector |
Basic Materials |
Industry |
Agricultural Inputs |
| Market Cap |
64,606,384 |
Cash |
43,901,000 |
| Debt |
284,124,000 |
Recommendation |
none |
| RSI |
47.9 |
MACD |
-0.08 |
| Signal |
-0.09 |
Histogram |
0.02 |
| Revenue Growth |
-10.0% |
EPS Growth |
N/A |
| Gross Margin |
29.0% |
ROE |
-26.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
7.0
|
AVO
|
Mission Produce, Inc.
|
12.82
|
none
|
-24%
/
2%
|
52%
|
48.9
↑
|
-0.05
|
0.07
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Food Distribution |
| Market Cap |
1,127,843,968 |
Cash |
33,000,000 |
| Debt |
217,700,000 |
Recommendation |
none |
| RSI |
48.9 |
MACD |
0.03 |
| Signal |
0.08 |
Histogram |
-0.05 |
| Revenue Growth |
-24.0% |
EPS Growth |
N/A |
| Gross Margin |
12.0% |
ROE |
4.0% |
| Target Price |
16.50 |
Analysts |
4 |
|
|
-28.0
|
AVXL
|
Anavex Life Sciences Corp.
|
2.87
|
none
|
N/A
/
0%
|
7%
|
45.1
↑
|
-0.07
|
-0.28
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
277,163,552 |
Cash |
118,326,000 |
| Debt |
0 |
Recommendation |
none |
| RSI |
45.1 |
MACD |
0.05 |
| Signal |
0.12 |
Histogram |
-0.07 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-13.0% |
| Target Price |
20.00 |
Analysts |
1 |
|
|
1.0
|
AXS
|
Axis Capital Holdings Limited
|
99.80
|
buy
|
7%
/
16%
|
39%
|
40.8
↑
|
0.18
|
0.01
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Specialty |
| Market Cap |
7,261,607,936 |
Cash |
782,830,016 |
| Debt |
1,486,957,952 |
Recommendation |
buy |
| RSI |
40.8 |
MACD |
-2.18 |
| Signal |
-2.36 |
Histogram |
0.18 |
| Revenue Growth |
7.0% |
EPS Growth |
24.0% |
| Gross Margin |
31.0% |
ROE |
17.0% |
| Target Price |
124.18 |
Analysts |
11 |
|
|
20.0
|
AXSM
|
Axsome Therapeutics, Inc.
|
202.83
|
strong_buy
|
46%
/
-25%
|
63%
|
37.2
↑
|
-0.43
|
0.20
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
10,424,829,952 |
Cash |
319,849,984 |
| Debt |
224,692,992 |
Recommendation |
strong_buy |
| RSI |
37.2 |
MACD |
-6.54 |
| Signal |
-6.11 |
Histogram |
-0.43 |
| Revenue Growth |
46.0% |
EPS Growth |
N/A |
| Gross Margin |
93.0% |
ROE |
-245.0% |
| Target Price |
285.42 |
Analysts |
21 |
|
|
-32.0
|
BALY
|
Bally's Corporation
|
9.09
|
hold
|
20%
/
-26%
|
2%
|
34.1
↑
|
-0.19
|
-0.32
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Resorts & Casinos |
| Market Cap |
475,927,584 |
Cash |
390,256,992 |
| Debt |
6,905,019,904 |
Recommendation |
hold |
| RSI |
34.1 |
MACD |
-1.25 |
| Signal |
-1.06 |
Histogram |
-0.19 |
| Revenue Growth |
20.0% |
EPS Growth |
N/A |
| Gross Margin |
58.0% |
ROE |
-57.0% |
| Target Price |
9.33 |
Analysts |
3 |
|
|
133.0
|
BAND
|
Bandwidth Inc.
|
50.79
|
buy
|
22%
/
0%
|
58%
|
49.0
↑
|
0.44
|
1.33
|
▼ |
| Sector |
Technology |
Industry |
Software - Infrastructure |
| Market Cap |
1,576,858,624 |
Cash |
174,356,992 |
| Debt |
554,420,992 |
Recommendation |
buy |
| RSI |
49.0 |
MACD |
-1.68 |
| Signal |
-2.12 |
Histogram |
0.44 |
| Revenue Growth |
22.0% |
EPS Growth |
N/A |
| Gross Margin |
37.0% |
ROE |
1.0% |
| Target Price |
70.75 |
Analysts |
4 |
|
|
14.0
|
BATRA
|
Atlanta Braves Holdings, Inc. -
|
55.46
|
none
|
-2%
/
-9%
|
85%
|
47.7
↑
|
-0.10
|
0.14
|
▼ |
| Sector |
Communication Services |
Industry |
Entertainment |
| Market Cap |
3,575,435,264 |
Cash |
116,278,000 |
| Debt |
896,691,008 |
Recommendation |
none |
| RSI |
47.7 |
MACD |
0.21 |
| Signal |
0.31 |
Histogram |
-0.10 |
| Revenue Growth |
-2.0% |
EPS Growth |
N/A |
| Gross Margin |
25.0% |
ROE |
-12.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
12.0
|
BATRK
|
Atlanta Braves Holdings, Inc. -
|
50.21
|
buy
|
-2%
/
-9%
|
78%
|
43.5
↑
|
-0.30
|
0.12
|
▼ |
| Sector |
Communication Services |
Industry |
Entertainment |
| Market Cap |
3,243,687,168 |
Cash |
116,278,000 |
| Debt |
896,691,008 |
Recommendation |
buy |
| RSI |
43.5 |
MACD |
-0.07 |
| Signal |
0.23 |
Histogram |
-0.30 |
| Revenue Growth |
-2.0% |
EPS Growth |
N/A |
| Gross Margin |
25.0% |
ROE |
-12.0% |
| Target Price |
61.20 |
Analysts |
5 |
|
|
-31.0
|
BBW
|
Build-A-Bear Workshop, Inc.
|
30.40
|
strong_buy
|
-7%
/
10%
|
4%
|
35.9
↑
|
-1.07
|
-0.31
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Specialty Retail |
| Market Cap |
374,242,688 |
Cash |
14,004,000 |
| Debt |
125,511,000 |
Recommendation |
strong_buy |
| RSI |
35.9 |
MACD |
-0.50 |
| Signal |
0.56 |
Histogram |
-1.07 |
| Revenue Growth |
-7.0% |
EPS Growth |
-26.0% |
| Gross Margin |
55.0% |
ROE |
33.0% |
| Target Price |
61.25 |
Analysts |
4 |
|
|
17.0
|
BBY
|
Best Buy Co., Inc.
|
82.63
|
hold
|
4%
/
3%
|
79%
|
46.6
↑
|
-0.68
|
0.17
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Specialty Retail |
| Market Cap |
17,375,641,600 |
Cash |
2,255,000,064 |
| Debt |
4,132,999,936 |
Recommendation |
hold |
| RSI |
46.6 |
MACD |
0.13 |
| Signal |
0.81 |
Histogram |
-0.68 |
| Revenue Growth |
4.0% |
EPS Growth |
70.0% |
| Gross Margin |
23.0% |
ROE |
43.0% |
| Target Price |
83.40 |
Analysts |
20 |
|
|
36.0
|
BCAX
|
Bicara Therapeutics Inc.
|
23.42
|
buy
|
N/A
/
0%
|
65%
|
41.4
↑
|
-0.12
|
0.36
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
1,550,431,872 |
Cash |
497,259,008 |
| Debt |
1,163,000 |
Recommendation |
buy |
| RSI |
41.4 |
MACD |
-0.70 |
| Signal |
-0.58 |
Histogram |
-0.12 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-41.0% |
| Target Price |
33.50 |
Analysts |
14 |
|
|
1.0
|
BCML
|
BayCom Corp
|
29.85
|
hold
|
-18%
/
14%
|
41%
|
37.4
↑
|
-0.02
|
0.01
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
330,770,368 |
Cash |
177,382,000 |
| Debt |
46,580,000 |
Recommendation |
hold |
| RSI |
37.4 |
MACD |
-0.48 |
| Signal |
-0.47 |
Histogram |
-0.02 |
| Revenue Growth |
-18.0% |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
4.0% |
| Target Price |
32.00 |
Analysts |
3 |
|
|
0.0
|
BCO
|
Brinks Company (The)
|
110.02
|
none
|
7%
/
3%
|
42%
|
45.7
↑
|
-0.55
|
0.00
|
▼ |
| Sector |
Industrials |
Industry |
Security & Protection Services |
| Market Cap |
4,569,858,560 |
Cash |
1,658,599,936 |
| Debt |
4,555,599,872 |
Recommendation |
none |
| RSI |
45.7 |
MACD |
-0.71 |
| Signal |
-0.16 |
Histogram |
-0.55 |
| Revenue Growth |
7.0% |
EPS Growth |
4.0% |
| Gross Margin |
26.0% |
ROE |
46.0% |
| Target Price |
150.50 |
Analysts |
2 |
|
|
73.0
|
BE
|
Bloom Energy Corporation
|
213.63
|
buy
|
166%
/
8%
|
55%
|
48.1
↑
|
0.79
|
0.73
|
▼ |
| Sector |
Industrials |
Industry |
Electrical Equipment & Parts |
| Market Cap |
62,077,534,208 |
Cash |
2,716,858,880 |
| Debt |
2,815,023,104 |
Recommendation |
buy |
| RSI |
48.1 |
MACD |
-4.25 |
| Signal |
-5.04 |
Histogram |
0.79 |
| Revenue Growth |
166.0% |
EPS Growth |
N/A |
| Gross Margin |
32.0% |
ROE |
22.0% |
| Target Price |
275.08 |
Analysts |
26 |
|
|
176.0
|
BFLY
|
Butterfly Network, Inc.
|
8.18
|
none
|
40%
/
-67%
|
81%
|
47.1
↑
|
-0.18
|
1.76
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Devices |
| Market Cap |
2,244,784,128 |
Cash |
124,659,000 |
| Debt |
19,097,000 |
Recommendation |
none |
| RSI |
47.1 |
MACD |
0.18 |
| Signal |
0.37 |
Histogram |
-0.18 |
| Revenue Growth |
40.0% |
EPS Growth |
N/A |
| Gross Margin |
68.0% |
ROE |
-35.0% |
| Target Price |
9.31 |
Analysts |
4 |
|
|
2.0
|
BFS
|
Saul Centers, Inc.
|
32.75
|
none
|
8%
/
12%
|
51%
|
33.5
↑
|
-0.11
|
0.02
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
1,155,433,984 |
Cash |
8,346,000 |
| Debt |
1,604,742,016 |
Recommendation |
none |
| RSI |
33.5 |
MACD |
-0.52 |
| Signal |
-0.41 |
Histogram |
-0.11 |
| Revenue Growth |
8.0% |
EPS Growth |
-27.0% |
| Gross Margin |
70.0% |
ROE |
10.0% |
| Target Price |
43.00 |
Analysts |
2 |
|
|
-15.0
|
BGS
|
B&G Foods, Inc.
|
3.49
|
none
|
-10%
/
-4%
|
7%
|
46.6
↑
|
0.01
|
-0.15
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Packaged Foods |
| Market Cap |
286,090,368 |
Cash |
591,576,000 |
| Debt |
2,575,214,080 |
Recommendation |
none |
| RSI |
46.6 |
MACD |
-0.05 |
| Signal |
-0.06 |
Histogram |
0.01 |
| Revenue Growth |
-10.0% |
EPS Growth |
N/A |
| Gross Margin |
22.0% |
ROE |
-16.0% |
| Target Price |
4.20 |
Analysts |
5 |
|
|
26.0
|
BHE
|
Benchmark Electronics, Inc.
|
70.48
|
none
|
18%
/
2%
|
55%
|
35.1
↑
|
-0.61
|
0.26
|
▼ |
| Sector |
Technology |
Industry |
Electronic Components |
| Market Cap |
2,561,450,240 |
Cash |
314,836,000 |
| Debt |
291,819,008 |
Recommendation |
none |
| RSI |
35.1 |
MACD |
-3.07 |
| Signal |
-2.46 |
Histogram |
-0.61 |
| Revenue Growth |
18.0% |
EPS Growth |
1,937.0% |
| Gross Margin |
10.0% |
ROE |
5.0% |
| Target Price |
86.00 |
Analysts |
3 |
|
|
-9.0
|
BIOA
|
BioAge Labs, Inc.
|
9.52
|
none
|
2%
/
0%
|
24%
|
33.0
↑
|
0.30
|
-0.09
|
▼ |
| Sector |
Healthcare |
Industry |
Drug Manufacturers - Specialty & Generic |
| Market Cap |
442,905,152 |
Cash |
318,744,992 |
| Debt |
2,835,000 |
Recommendation |
none |
| RSI |
33.0 |
MACD |
-2.11 |
| Signal |
-2.41 |
Histogram |
0.30 |
| Revenue Growth |
2.0% |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-28.0% |
| Target Price |
35.62 |
Analysts |
8 |
|
|
-1.0
|
BJ
|
BJ's Wholesale Club Holdings, I
|
91.48
|
buy
|
16%
/
3%
|
40%
|
45.0
↑
|
-0.55
|
-0.01
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Discount Stores |
| Market Cap |
11,444,110,336 |
Cash |
29,982,000 |
| Debt |
2,773,323,008 |
Recommendation |
buy |
| RSI |
45.0 |
MACD |
-0.36 |
| Signal |
0.19 |
Histogram |
-0.55 |
| Revenue Growth |
16.0% |
EPS Growth |
19.0% |
| Gross Margin |
18.0% |
ROE |
28.0% |
| Target Price |
105.65 |
Analysts |
20 |
|
|
7.0
|
BKD
|
Brookdale Senior Living Inc.
|
11.90
|
strong_buy
|
-9%
/
-5%
|
48%
|
33.0
↑
|
-0.02
|
0.07
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
2,798,938,112 |
Cash |
390,292,000 |
| Debt |
5,490,885,120 |
Recommendation |
strong_buy |
| RSI |
33.0 |
MACD |
-0.64 |
| Signal |
-0.62 |
Histogram |
-0.02 |
| Revenue Growth |
-9.0% |
EPS Growth |
N/A |
| Gross Margin |
28.0% |
ROE |
-350.0% |
| Target Price |
19.25 |
Analysts |
6 |
|
|
7.0
|
BKH
|
Black Hills Corporation
|
72.40
|
none
|
3%
/
13%
|
84%
|
47.8
↑
|
-0.04
|
0.07
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Gas |
| Market Cap |
5,551,228,928 |
Cash |
71,500,000 |
| Debt |
4,493,899,776 |
Recommendation |
none |
| RSI |
47.8 |
MACD |
-0.08 |
| Signal |
-0.05 |
Histogram |
-0.04 |
| Revenue Growth |
3.0% |
EPS Growth |
32.0% |
| Gross Margin |
40.0% |
ROE |
8.0% |
| Target Price |
84.80 |
Analysts |
5 |
|
|
-4.0
|
BKTI
|
BK Technologies Corporation
|
72.72
|
strong_buy
|
11%
/
15%
|
30%
|
37.6
↑
|
-0.31
|
-0.04
|
▼ |
| Sector |
Technology |
Industry |
Communication Equipment |
| Market Cap |
273,959,200 |
Cash |
29,917,000 |
| Debt |
1,296,000 |
Recommendation |
strong_buy |
| RSI |
37.6 |
MACD |
-1.49 |
| Signal |
-1.18 |
Histogram |
-0.31 |
| Revenue Growth |
11.0% |
EPS Growth |
-18.0% |
| Gross Margin |
51.0% |
ROE |
31.0% |
| Target Price |
97.00 |
Analysts |
1 |
|
|
0.0
|
BLBD
|
Blue Bird Corporation
|
60.55
|
strong_buy
|
30%
/
17%
|
40%
|
38.3
↑
|
-0.10
|
0.00
|
▼ |
| Sector |
Industrials |
Industry |
Farm & Heavy Construction Machinery |
| Market Cap |
1,874,427,392 |
Cash |
116,824,000 |
| Debt |
115,751,000 |
Recommendation |
strong_buy |
| RSI |
38.3 |
MACD |
-3.75 |
| Signal |
-3.65 |
Histogram |
-0.10 |
| Revenue Growth |
30.0% |
EPS Growth |
370.0% |
| Gross Margin |
21.0% |
ROE |
64.0% |
| Target Price |
89.12 |
Analysts |
8 |
|
|
11.0
|
BLX
|
Bladex, Inc. Class E
|
54.22
|
strong_buy
|
6%
/
71%
|
63%
|
40.6
↑
|
0.01
|
0.11
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
N/A |
Cash |
632,032,000 |
| Debt |
4,493,586,944 |
Recommendation |
strong_buy |
| RSI |
40.6 |
MACD |
-0.93 |
| Signal |
-0.94 |
Histogram |
0.01 |
| Revenue Growth |
6.0% |
EPS Growth |
2.0% |
| Gross Margin |
0.0% |
ROE |
15.0% |
| Target Price |
65.90 |
Analysts |
4 |
|
|
5.0
|
BNTC
|
Benitec Biopharma Inc.
|
12.31
|
strong_buy
|
N/A
/
0%
|
35%
|
45.7
↑
|
-0.10
|
0.05
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
428,398,592 |
Cash |
184,760,992 |
| Debt |
876,000 |
Recommendation |
strong_buy |
| RSI |
45.7 |
MACD |
0.02 |
| Signal |
0.12 |
Histogram |
-0.10 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-30.0% |
| Target Price |
24.17 |
Analysts |
6 |
|
|
1.0
|
BRT
|
BRT Apartments Corp. (MD)
|
14.43
|
buy
|
0%
/
21%
|
55%
|
46.4
↑
|
0.00
|
0.01
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Residential |
| Market Cap |
273,442,176 |
Cash |
22,718,000 |
| Debt |
508,484,992 |
Recommendation |
buy |
| RSI |
46.4 |
MACD |
-0.06 |
| Signal |
-0.06 |
Histogram |
0.00 |
| Revenue Growth |
0.0% |
EPS Growth |
N/A |
| Gross Margin |
51.0% |
ROE |
21.0% |
| Target Price |
18.00 |
Analysts |
3 |
|
|
4.0
|
BRX
|
Brixmor Property Group Inc.
|
29.26
|
strong_buy
|
4%
/
31%
|
61%
|
37.4
↑
|
-0.03
|
0.04
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
8,951,465,984 |
Cash |
170,888,992 |
| Debt |
5,378,705,920 |
Recommendation |
strong_buy |
| RSI |
37.4 |
MACD |
-0.53 |
| Signal |
-0.50 |
Histogram |
-0.03 |
| Revenue Growth |
4.0% |
EPS Growth |
-14.0% |
| Gross Margin |
75.0% |
ROE |
14.0% |
| Target Price |
35.44 |
Analysts |
18 |
|
|
-30.0
|
BTMD
|
Biote Corp.
|
1.67
|
none
|
-10%
/
3%
|
17%
|
47.2
↑
|
0.04
|
-0.30
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
53,221,808 |
Cash |
11,168,000 |
| Debt |
128,640,000 |
Recommendation |
none |
| RSI |
47.2 |
MACD |
-0.12 |
| Signal |
-0.16 |
Histogram |
0.04 |
| Revenue Growth |
-10.0% |
EPS Growth |
N/A |
| Gross Margin |
69.0% |
ROE |
N/A |
| Target Price |
2.61 |
Analysts |
5 |
|
|
49.0
|
BTSG
|
BrightSpring Health Services, I
|
59.16
|
strong_buy
|
23%
/
3%
|
72%
|
43.9
↑
|
0.16
|
0.49
|
▼ |
| Sector |
Healthcare |
Industry |
Health Information Services |
| Market Cap |
11,699,713,024 |
Cash |
550,380,992 |
| Debt |
2,387,651,072 |
Recommendation |
strong_buy |
| RSI |
43.9 |
MACD |
-1.72 |
| Signal |
-1.88 |
Histogram |
0.16 |
| Revenue Growth |
23.0% |
EPS Growth |
197.0% |
| Gross Margin |
12.0% |
ROE |
13.0% |
| Target Price |
78.94 |
Analysts |
17 |
|
|
-38.0
|
BUR
|
Burford Capital Limited
|
4.21
|
buy
|
-37%
/
0%
|
3%
|
47.0
↑
|
-0.01
|
-0.38
|
▼ |
| Sector |
Financial Services |
Industry |
Asset Management |
| Market Cap |
957,388,416 |
Cash |
747,260,032 |
| Debt |
2,415,348,992 |
Recommendation |
buy |
| RSI |
47.0 |
MACD |
0.00 |
| Signal |
0.02 |
Histogram |
-0.01 |
| Revenue Growth |
-37.0% |
EPS Growth |
-97.0% |
| Gross Margin |
0.0% |
ROE |
-72.0% |
| Target Price |
8.67 |
Analysts |
6 |
|
|
-12.0
|
BWXT
|
BWX Technologies, Inc.
|
161.54
|
buy
|
18%
/
10%
|
14%
|
46.9
↑
|
-0.01
|
-0.12
|
▼ |
| Sector |
Industrials |
Industry |
Aerospace & Defense |
| Market Cap |
14,004,420,608 |
Cash |
608,203,008 |
| Debt |
2,019,896,960 |
Recommendation |
buy |
| RSI |
46.9 |
MACD |
-5.65 |
| Signal |
-5.64 |
Histogram |
-0.01 |
| Revenue Growth |
18.0% |
EPS Growth |
14.0% |
| Gross Margin |
22.0% |
ROE |
28.0% |
| Target Price |
234.45 |
Analysts |
14 |
|
|
-6.0
|
CALM
|
Cal-Maine Foods, Inc.
|
79.02
|
none
|
-50%
/
11%
|
18%
|
38.0
↑
|
-0.39
|
-0.06
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Farm Products |
| Market Cap |
3,746,287,616 |
Cash |
924,057,024 |
| Debt |
0 |
Recommendation |
none |
| RSI |
38.0 |
MACD |
-1.22 |
| Signal |
-0.83 |
Histogram |
-0.39 |
| Revenue Growth |
-50.0% |
EPS Growth |
N/A |
| Gross Margin |
23.0% |
ROE |
12.0% |
| Target Price |
88.00 |
Analysts |
4 |
|
|
21.0
|
CASY
|
Caseys General Stores, Inc.
|
766.91
|
buy
|
14%
/
4%
|
65%
|
36.3
↑
|
-10.61
|
0.21
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Specialty Retail |
| Market Cap |
27,956,099,072 |
Cash |
522,991,008 |
| Debt |
2,905,074,944 |
Recommendation |
buy |
| RSI |
36.3 |
MACD |
-17.18 |
| Signal |
-6.56 |
Histogram |
-10.61 |
| Revenue Growth |
14.0% |
EPS Growth |
66.0% |
| Gross Margin |
25.0% |
ROE |
19.0% |
| Target Price |
957.39 |
Analysts |
18 |
|
|
-44.0
|
CCB
|
Coastal Financial Corporation
|
47.17
|
none
|
-2%
/
-1%
|
9%
|
36.8
↑
|
0.88
|
-0.44
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
741,081,152 |
Cash |
1,008,448,000 |
| Debt |
52,634,000 |
Recommendation |
none |
| RSI |
36.8 |
MACD |
-4.13 |
| Signal |
-5.01 |
Histogram |
0.88 |
| Revenue Growth |
-2.0% |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-1.0% |
| Target Price |
49.50 |
Analysts |
4 |
|
|
20.0
|
CCK
|
Crown Holdings, Inc.
|
116.66
|
none
|
16%
/
6%
|
84%
|
47.5
↑
|
-0.61
|
0.20
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Packaging & Containers |
| Market Cap |
12,881,595,392 |
Cash |
656,000,000 |
| Debt |
6,272,000,000 |
Recommendation |
none |
| RSI |
47.5 |
MACD |
0.57 |
| Signal |
1.18 |
Histogram |
-0.61 |
| Revenue Growth |
16.0% |
EPS Growth |
43.0% |
| Gross Margin |
21.0% |
ROE |
27.0% |
| Target Price |
136.57 |
Analysts |
14 |
|
|
-62.0
|
CD
|
Chaince Digital Holdings Inc. -
|
3.03
|
none
|
98%
/
-183%
|
1%
|
43.8
↑
|
-0.01
|
-0.62
|
▼ |
| Sector |
Financial Services |
Industry |
Capital Markets |
| Market Cap |
358,612,384 |
Cash |
43,776,752 |
| Debt |
949,559 |
Recommendation |
none |
| RSI |
43.8 |
MACD |
-0.08 |
| Signal |
-0.07 |
Histogram |
-0.01 |
| Revenue Growth |
98.0% |
EPS Growth |
N/A |
| Gross Margin |
60.0% |
ROE |
-8.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
-1.0
|
CELC
|
Celcuity Inc.
|
91.98
|
strong_buy
|
N/A
/
0%
|
47%
|
49.7
↑
|
0.30
|
-0.01
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
4,327,538,176 |
Cash |
754,044,032 |
| Debt |
754,385,024 |
Recommendation |
strong_buy |
| RSI |
49.7 |
MACD |
-0.31 |
| Signal |
-0.61 |
Histogram |
0.30 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-1,434.0% |
| Target Price |
161.09 |
Analysts |
11 |
|
|
-4.0
|
CHCT
|
Community Healthcare Trust Inco
|
14.89
|
none
|
7%
/
17%
|
45%
|
38.5
↑
|
0.09
|
-0.04
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Healthcare Facilities |
| Market Cap |
428,374,944 |
Cash |
11,720,000 |
| Debt |
563,302,016 |
Recommendation |
none |
| RSI |
38.5 |
MACD |
-0.56 |
| Signal |
-0.65 |
Histogram |
0.09 |
| Revenue Growth |
7.0% |
EPS Growth |
N/A |
| Gross Margin |
81.0% |
ROE |
5.0% |
| Target Price |
18.25 |
Analysts |
4 |
|
|
-31.0
|
CIA
|
Citizens, Inc.
|
3.81
|
none
|
-7%
/
5%
|
3%
|
34.4
↑
|
0.04
|
-0.31
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Life |
| Market Cap |
194,469,536 |
Cash |
15,406,000 |
| Debt |
0 |
Recommendation |
none |
| RSI |
34.4 |
MACD |
-0.28 |
| Signal |
-0.32 |
Histogram |
0.04 |
| Revenue Growth |
-7.0% |
EPS Growth |
N/A |
| Gross Margin |
27.0% |
ROE |
5.0% |
| Target Price |
5.00 |
Analysts |
1 |
|
|
7.0
|
CINF
|
Cincinnati Financial Corporatio
|
170.39
|
none
|
32%
/
24%
|
50%
|
42.4
↑
|
0.03
|
0.07
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Property & Casualty |
| Market Cap |
26,393,620,480 |
Cash |
1,892,000,000 |
| Debt |
876,000,000 |
Recommendation |
none |
| RSI |
42.4 |
MACD |
-1.79 |
| Signal |
-1.82 |
Histogram |
0.03 |
| Revenue Growth |
32.0% |
EPS Growth |
86.0% |
| Gross Margin |
31.0% |
ROE |
21.0% |
| Target Price |
191.67 |
Analysts |
6 |
|
|
60.0
|
CLDT
|
Chatham Lodging Trust (REIT)
|
13.08
|
none
|
9%
/
4%
|
91%
|
47.8
↑
|
-0.02
|
0.60
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Hotel & Motel |
| Market Cap |
669,346,880 |
Cash |
11,342,000 |
| Debt |
434,049,984 |
Recommendation |
none |
| RSI |
47.8 |
MACD |
0.08 |
| Signal |
0.10 |
Histogram |
-0.02 |
| Revenue Growth |
9.0% |
EPS Growth |
91.0% |
| Gross Margin |
49.0% |
ROE |
2.0% |
| Target Price |
14.08 |
Analysts |
3 |
|
|
-27.0
|
CLNE
|
Clean Energy Fuels Corp.
|
1.61
|
buy
|
4%
/
-21%
|
3%
|
39.1
↑
|
0.01
|
-0.27
|
▼ |
| Sector |
Energy |
Industry |
Oil & Gas Refining & Marketing |
| Market Cap |
359,325,376 |
Cash |
137,978,000 |
| Debt |
322,566,016 |
Recommendation |
buy |
| RSI |
39.1 |
MACD |
-0.10 |
| Signal |
-0.10 |
Histogram |
0.01 |
| Revenue Growth |
4.0% |
EPS Growth |
N/A |
| Gross Margin |
28.0% |
ROE |
-16.0% |
| Target Price |
4.03 |
Analysts |
6 |
|
|
53.0
|
CLOV
|
Clover Health Investments, Corp
|
4.30
|
none
|
56%
/
-1%
|
70%
|
48.9
↑
|
0.00
|
0.53
|
▼ |
| Sector |
Healthcare |
Industry |
Healthcare Plans |
| Market Cap |
2,246,790,912 |
Cash |
243,100,000 |
| Debt |
0 |
Recommendation |
none |
| RSI |
48.9 |
MACD |
-0.08 |
| Signal |
-0.08 |
Histogram |
0.00 |
| Revenue Growth |
56.0% |
EPS Growth |
N/A |
| Gross Margin |
19.0% |
ROE |
-5.0% |
| Target Price |
5.17 |
Analysts |
3 |
|
|
11.0
|
CNA
|
CNA Financial Corporation
|
48.68
|
none
|
3%
/
8%
|
57%
|
39.6
↑
|
-0.25
|
0.11
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Property & Casualty |
| Market Cap |
13,343,332,352 |
Cash |
2,060,000,000 |
| Debt |
2,972,999,936 |
Recommendation |
none |
| RSI |
39.6 |
MACD |
-0.55 |
| Signal |
-0.30 |
Histogram |
-0.25 |
| Revenue Growth |
3.0% |
EPS Growth |
7.0% |
| Gross Margin |
31.0% |
ROE |
11.0% |
| Target Price |
49.00 |
Analysts |
1 |
|
|
8.0
|
CPSS
|
Consumer Portfolio Services, In
|
9.24
|
none
|
19%
/
10%
|
65%
|
47.3
↑
|
-0.00
|
0.08
|
▼ |
| Sector |
Financial Services |
Industry |
Credit Services |
| Market Cap |
203,045,408 |
Cash |
7,501,000 |
| Debt |
4,025,783,040 |
Recommendation |
none |
| RSI |
47.3 |
MACD |
-0.03 |
| Signal |
-0.02 |
Histogram |
-0.00 |
| Revenue Growth |
19.0% |
EPS Growth |
35.0% |
| Gross Margin |
100.0% |
ROE |
7.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
1.0
|
CPT
|
Camden Property Trust
|
105.96
|
hold
|
-1%
/
21%
|
49%
|
37.7
↑
|
-0.24
|
0.01
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Residential |
| Market Cap |
12,308,159,488 |
Cash |
44,717,000 |
| Debt |
4,873,028,096 |
Recommendation |
hold |
| RSI |
37.7 |
MACD |
-1.45 |
| Signal |
-1.21 |
Histogram |
-0.24 |
| Revenue Growth |
-1.0% |
EPS Growth |
-76.0% |
| Gross Margin |
62.0% |
ROE |
8.0% |
| Target Price |
117.42 |
Analysts |
22 |
|
|
45.0
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
14.27
|
none
|
N/A
/
0%
|
43%
|
49.2
↑
|
-0.06
|
0.45
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
1,191,152,512 |
Cash |
215,228,000 |
| Debt |
728,000 |
Recommendation |
none |
| RSI |
49.2 |
MACD |
0.10 |
| Signal |
0.16 |
Histogram |
-0.06 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-35.0% |
| Target Price |
33.14 |
Analysts |
7 |
|
|
23.0
|
CSTM
|
Constellium SE
|
26.91
|
strong_buy
|
31%
/
6%
|
59%
|
41.7
↑
|
-0.08
|
0.23
|
▼ |
| Sector |
Basic Materials |
Industry |
Aluminum |
| Market Cap |
3,656,538,112 |
Cash |
163,000,000 |
| Debt |
1,923,000,064 |
Recommendation |
strong_buy |
| RSI |
41.7 |
MACD |
-0.75 |
| Signal |
-0.67 |
Histogram |
-0.08 |
| Revenue Growth |
31.0% |
EPS Growth |
316.0% |
| Gross Margin |
17.0% |
ROE |
53.0% |
| Target Price |
37.63 |
Analysts |
5 |
|
|
18.0
|
CTO
|
CTO Realty Growth, Inc.
|
21.50
|
none
|
16%
/
33%
|
87%
|
44.2
↑
|
-0.07
|
0.18
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Diversified |
| Market Cap |
808,561,280 |
Cash |
14,127,000 |
| Debt |
658,876,992 |
Recommendation |
none |
| RSI |
44.2 |
MACD |
-0.04 |
| Signal |
0.03 |
Histogram |
-0.07 |
| Revenue Growth |
16.0% |
EPS Growth |
N/A |
| Gross Margin |
75.0% |
ROE |
8.0% |
| Target Price |
24.60 |
Analysts |
5 |
|
|
7.0
|
CTRE
|
CareTrust REIT, Inc.
|
39.93
|
strong_buy
|
3%
/
62%
|
70%
|
49.0
↑
|
0.01
|
0.07
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Healthcare Facilities |
| Market Cap |
9,222,522,880 |
Cash |
30,469,000 |
| Debt |
665,836,032 |
Recommendation |
strong_buy |
| RSI |
49.0 |
MACD |
-0.35 |
| Signal |
-0.36 |
Histogram |
0.01 |
| Revenue Growth |
3.0% |
EPS Growth |
5.0% |
| Gross Margin |
96.0% |
ROE |
9.0% |
| Target Price |
45.38 |
Analysts |
13 |
|
|
-21.0
|
CTRI
|
Centuri Holdings, Inc.
|
20.49
|
buy
|
33%
/
1%
|
5%
|
32.7
↑
|
-0.07
|
-0.21
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Gas |
| Market Cap |
2,051,569,280 |
Cash |
40,458,000 |
| Debt |
947,209,024 |
Recommendation |
buy |
| RSI |
32.7 |
MACD |
-1.50 |
| Signal |
-1.43 |
Histogram |
-0.07 |
| Revenue Growth |
33.0% |
EPS Growth |
-33.0% |
| Gross Margin |
8.0% |
ROE |
4.0% |
| Target Price |
31.75 |
Analysts |
6 |
|
|
3.0
|
CUBE
|
CubeSmart
|
39.73
|
buy
|
2%
/
29%
|
68%
|
35.6
↑
|
-0.21
|
0.03
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Industrial |
| Market Cap |
9,058,805,760 |
Cash |
14,310,000 |
| Debt |
3,541,499,904 |
Recommendation |
buy |
| RSI |
35.6 |
MACD |
-0.32 |
| Signal |
-0.11 |
Histogram |
-0.21 |
| Revenue Growth |
2.0% |
EPS Growth |
8.0% |
| Gross Margin |
71.0% |
ROE |
12.0% |
| Target Price |
44.12 |
Analysts |
16 |
|
|
9.0
|
CV
|
CapsoVision, Inc.
|
5.87
|
strong_buy
|
10%
/
-215%
|
21%
|
39.9
↑
|
-0.05
|
0.09
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Devices |
| Market Cap |
296,778,176 |
Cash |
9,077,000 |
| Debt |
687,000 |
Recommendation |
strong_buy |
| RSI |
39.9 |
MACD |
-0.23 |
| Signal |
-0.18 |
Histogram |
-0.05 |
| Revenue Growth |
10.0% |
EPS Growth |
N/A |
| Gross Margin |
51.0% |
ROE |
-335.0% |
| Target Price |
10.00 |
Analysts |
1 |
|
|
-56.0
|
CVRX
|
CVRx, Inc.
|
3.04
|
buy
|
16%
/
-85%
|
8%
|
40.2
↑
|
0.07
|
-0.56
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Devices |
| Market Cap |
78,592,712 |
Cash |
64,586,000 |
| Debt |
59,390,000 |
Recommendation |
buy |
| RSI |
40.2 |
MACD |
-0.44 |
| Signal |
-0.52 |
Histogram |
0.07 |
| Revenue Growth |
16.0% |
EPS Growth |
N/A |
| Gross Margin |
87.0% |
ROE |
-133.0% |
| Target Price |
4.58 |
Analysts |
6 |
|
|
8.0
|
CXT
|
Crane NXT, Co.
|
49.16
|
none
|
22%
/
8%
|
41%
|
44.5
↑
|
-0.26
|
0.08
|
▼ |
| Sector |
Industrials |
Industry |
Specialty Industrial Machinery |
| Market Cap |
2,885,548,288 |
Cash |
231,400,000 |
| Debt |
1,467,100,032 |
Recommendation |
none |
| RSI |
44.5 |
MACD |
-0.42 |
| Signal |
-0.16 |
Histogram |
-0.26 |
| Revenue Growth |
22.0% |
EPS Growth |
42.0% |
| Gross Margin |
42.0% |
ROE |
11.0% |
| Target Price |
70.17 |
Analysts |
6 |
|
|
-2.0
|
CYH
|
Community Health Systems, Inc.
|
2.93
|
hold
|
-10%
/
2%
|
23%
|
46.6
↑
|
0.01
|
-0.02
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
413,157,440 |
Cash |
149,000,000 |
| Debt |
10,204,999,680 |
Recommendation |
hold |
| RSI |
46.6 |
MACD |
-0.03 |
| Signal |
-0.03 |
Histogram |
0.01 |
| Revenue Growth |
-10.0% |
EPS Growth |
-76.0% |
| Gross Margin |
41.0% |
ROE |
N/A |
| Target Price |
3.18 |
Analysts |
7 |
|
|
12.0
|
CYTK
|
Cytokinetics, Incorporated
|
71.40
|
strong_buy
|
-57%
/
0%
|
60%
|
36.0
↑
|
-0.37
|
0.12
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
10,022,198,272 |
Cash |
1,165,686,016 |
| Debt |
1,424,455,040 |
Recommendation |
strong_buy |
| RSI |
36.0 |
MACD |
-1.26 |
| Signal |
-0.89 |
Histogram |
-0.37 |
| Revenue Growth |
-57.0% |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
N/A |
| Target Price |
109.90 |
Analysts |
20 |
|
|
-52.0
|
DCGO
|
DocGo Inc.
|
0.39
|
buy
|
-9%
/
-65%
|
0%
|
33.8
↑
|
-0.01
|
-0.52
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
39,324,028 |
Cash |
25,233,368 |
| Debt |
25,906,176 |
Recommendation |
buy |
| RSI |
33.8 |
MACD |
-0.06 |
| Signal |
-0.05 |
Histogram |
-0.01 |
| Revenue Growth |
-9.0% |
EPS Growth |
N/A |
| Gross Margin |
30.0% |
ROE |
-108.0% |
| Target Price |
1.88 |
Analysts |
4 |
|
|
31.0
|
DHC
|
Diversified Healthcare Trust
|
7.63
|
buy
|
-4%
/
-18%
|
66%
|
31.2
↑
|
-0.05
|
0.31
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Healthcare Facilities |
| Market Cap |
1,852,286,848 |
Cash |
116,846,000 |
| Debt |
2,417,933,056 |
Recommendation |
buy |
| RSI |
31.2 |
MACD |
-0.30 |
| Signal |
-0.26 |
Histogram |
-0.05 |
| Revenue Growth |
-4.0% |
EPS Growth |
N/A |
| Gross Margin |
19.0% |
ROE |
-15.0% |
| Target Price |
10.15 |
Analysts |
4 |
|
|
-1.0
|
DMAC
|
DiaMedica Therapeutics Inc.
|
6.45
|
none
|
N/A
/
0%
|
28%
|
43.7
↑
|
-0.02
|
-0.01
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
344,585,184 |
Cash |
43,504,000 |
| Debt |
185,000 |
Recommendation |
none |
| RSI |
43.7 |
MACD |
-0.06 |
| Signal |
-0.05 |
Histogram |
-0.02 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-115.0% |
| Target Price |
15.50 |
Analysts |
4 |
|
|
-23.0
|
DNA
|
Ginkgo Bioworks Holdings, Inc.
|
6.93
|
underperform
|
-48%
/
-220%
|
14%
|
43.9
↑
|
0.01
|
-0.23
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
468,688,352 |
Cash |
302,163,008 |
| Debt |
404,112,992 |
Recommendation |
underperform |
| RSI |
43.9 |
MACD |
-0.34 |
| Signal |
-0.34 |
Histogram |
0.01 |
| Revenue Growth |
-48.0% |
EPS Growth |
N/A |
| Gross Margin |
68.0% |
ROE |
-60.0% |
| Target Price |
7.00 |
Analysts |
2 |
|
|
123.0
|
DNTH
|
Dianthus Therapeutics, Inc.
|
106.62
|
strong_buy
|
294%
/
0%
|
90%
|
47.5
↑
|
-1.23
|
1.23
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
5,920,094,208 |
Cash |
886,812,992 |
| Debt |
1,287,000 |
Recommendation |
strong_buy |
| RSI |
47.5 |
MACD |
1.35 |
| Signal |
2.58 |
Histogram |
-1.23 |
| Revenue Growth |
294.0% |
EPS Growth |
N/A |
| Gross Margin |
100.0% |
ROE |
-26.0% |
| Target Price |
137.62 |
Analysts |
13 |
|
|
-9.0
|
DRVN
|
Driven Brands Holdings Inc.
|
12.80
|
none
|
7%
/
9%
|
28%
|
43.7
↑
|
-0.00
|
-0.09
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Auto & Truck Dealerships |
| Market Cap |
2,057,298,304 |
Cash |
183,947,008 |
| Debt |
2,220,442,880 |
Recommendation |
none |
| RSI |
43.7 |
MACD |
-0.33 |
| Signal |
-0.33 |
Histogram |
-0.00 |
| Revenue Growth |
7.0% |
EPS Growth |
-37.0% |
| Gross Margin |
45.0% |
ROE |
21.0% |
| Target Price |
16.61 |
Analysts |
10 |
|
|
-1.0
|
DTE
|
DTE Energy Company
|
136.06
|
buy
|
-2%
/
8%
|
36%
|
37.6
↑
|
0.01
|
-0.01
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
28,270,843,904 |
Cash |
42,000,000 |
| Debt |
27,840,000,000 |
Recommendation |
buy |
| RSI |
37.6 |
MACD |
-2.25 |
| Signal |
-2.25 |
Histogram |
0.01 |
| Revenue Growth |
-2.0% |
EPS Growth |
22.0% |
| Gross Margin |
29.0% |
ROE |
11.0% |
| Target Price |
159.11 |
Analysts |
14 |
|
|
15.0
|
DVA
|
DaVita Inc.
|
176.14
|
none
|
5%
/
6%
|
53%
|
30.8
↑
|
0.93
|
0.15
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
11,527,383,040 |
Cash |
688,876,992 |
| Debt |
13,406,474,240 |
Recommendation |
none |
| RSI |
30.8 |
MACD |
-10.29 |
| Signal |
-11.22 |
Histogram |
0.93 |
| Revenue Growth |
5.0% |
EPS Growth |
56.0% |
| Gross Margin |
32.0% |
ROE |
88.0% |
| Target Price |
218.43 |
Analysts |
7 |
|
|
11.0
|
EBAY
|
eBay Inc.
|
104.98
|
hold
|
15%
/
19%
|
66%
|
47.4
↑
|
0.19
|
0.11
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Internet Retail |
| Market Cap |
47,000,899,584 |
Cash |
3,307,000,064 |
| Debt |
7,137,999,872 |
Recommendation |
hold |
| RSI |
47.4 |
MACD |
-1.65 |
| Signal |
-1.84 |
Histogram |
0.19 |
| Revenue Growth |
15.0% |
EPS Growth |
55.0% |
| Gross Margin |
72.0% |
ROE |
47.0% |
| Target Price |
116.15 |
Analysts |
27 |
|
|
6.0
|
ED
|
Consolidated Edison, Inc.
|
107.70
|
hold
|
13%
/
13%
|
72%
|
48.9
↑
|
0.05
|
0.06
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
39,752,880,128 |
Cash |
1,470,000,000 |
| Debt |
28,320,000,000 |
Recommendation |
hold |
| RSI |
48.9 |
MACD |
-0.42 |
| Signal |
-0.46 |
Histogram |
0.05 |
| Revenue Growth |
13.0% |
EPS Growth |
22.0% |
| Gross Margin |
53.0% |
ROE |
9.0% |
| Target Price |
110.28 |
Analysts |
16 |
|
|
10.0
|
EGP
|
EastGroup Properties, Inc.
|
200.07
|
buy
|
9%
/
41%
|
64%
|
38.9
↑
|
-0.12
|
0.10
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Industrial |
| Market Cap |
10,754,663,424 |
Cash |
47,349,000 |
| Debt |
1,647,885,952 |
Recommendation |
buy |
| RSI |
38.9 |
MACD |
-2.03 |
| Signal |
-1.91 |
Histogram |
-0.12 |
| Revenue Growth |
9.0% |
EPS Growth |
17.0% |
| Gross Margin |
74.0% |
ROE |
9.0% |
| Target Price |
228.40 |
Analysts |
20 |
|
|
-6.0
|
EIX
|
Edison International
|
58.80
|
hold
|
-4%
/
19%
|
29%
|
32.8
↑
|
-1.33
|
-0.06
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
27,002,396,672 |
Cash |
242,000,000 |
| Debt |
43,540,000,768 |
Recommendation |
hold |
| RSI |
32.8 |
MACD |
-2.34 |
| Signal |
-1.00 |
Histogram |
-1.33 |
| Revenue Growth |
-4.0% |
EPS Growth |
55.0% |
| Gross Margin |
61.0% |
ROE |
20.0% |
| Target Price |
76.25 |
Analysts |
14 |
|
|
3.0
|
EME
|
EMCOR Group, Inc.
|
735.25
|
buy
|
20%
/
8%
|
43%
|
39.5
↑
|
-9.01
|
0.03
|
▼ |
| Sector |
Industrials |
Industry |
Engineering & Construction |
| Market Cap |
32,648,824,832 |
Cash |
924,411,008 |
| Debt |
548,028,032 |
Recommendation |
buy |
| RSI |
39.5 |
MACD |
-12.05 |
| Signal |
-3.04 |
Histogram |
-9.01 |
| Revenue Growth |
20.0% |
EPS Growth |
35.0% |
| Gross Margin |
19.0% |
ROE |
40.0% |
| Target Price |
1033.29 |
Analysts |
7 |
|
|
-3.0
|
ENSG
|
The Ensign Group, Inc.
|
173.20
|
none
|
17%
/
7%
|
38%
|
41.2
↑
|
-1.47
|
-0.03
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
10,081,694,720 |
Cash |
320,844,000 |
| Debt |
2,250,345,984 |
Recommendation |
none |
| RSI |
41.2 |
MACD |
0.11 |
| Signal |
1.58 |
Histogram |
-1.47 |
| Revenue Growth |
17.0% |
EPS Growth |
17.0% |
| Gross Margin |
17.0% |
ROE |
17.0% |
| Target Price |
220.00 |
Analysts |
5 |
|
|
10.0
|
EPR
|
EPR Properties
|
59.36
|
buy
|
11%
/
36%
|
74%
|
42.3
↑
|
-0.26
|
0.10
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Specialty |
| Market Cap |
4,562,061,312 |
Cash |
16,277,000 |
| Debt |
3,524,897,024 |
Recommendation |
buy |
| RSI |
42.3 |
MACD |
-0.38 |
| Signal |
-0.11 |
Histogram |
-0.26 |
| Revenue Growth |
11.0% |
EPS Growth |
-13.0% |
| Gross Margin |
92.0% |
ROE |
11.0% |
| Target Price |
64.41 |
Analysts |
11 |
|
|
-1.0
|
EPRT
|
Essential Properties Realty Tru
|
30.12
|
strong_buy
|
18%
/
44%
|
34%
|
38.5
↑
|
-0.08
|
-0.01
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
6,585,606,656 |
Cash |
126,165,000 |
| Debt |
2,923,130,880 |
Recommendation |
strong_buy |
| RSI |
38.5 |
MACD |
-0.24 |
| Signal |
-0.15 |
Histogram |
-0.08 |
| Revenue Growth |
18.0% |
EPS Growth |
8.0% |
| Gross Margin |
98.0% |
ROE |
6.0% |
| Target Price |
37.06 |
Analysts |
20 |
|
|
-25.0
|
ERII
|
Energy Recovery, Inc.
|
7.73
|
none
|
-57%
/
13%
|
0%
|
40.3
↑
|
-0.01
|
-0.25
|
▼ |
| Sector |
Industrials |
Industry |
Pollution & Treatment Controls |
| Market Cap |
396,618,688 |
Cash |
93,056,000 |
| Debt |
8,233,000 |
Recommendation |
none |
| RSI |
40.3 |
MACD |
-0.20 |
| Signal |
-0.19 |
Histogram |
-0.01 |
| Revenue Growth |
-57.0% |
EPS Growth |
N/A |
| Gross Margin |
65.0% |
ROE |
9.0% |
| Target Price |
9.33 |
Analysts |
3 |
|
|
7.0
|
ES
|
Eversource Energy (D/B/A)
|
70.50
|
hold
|
2%
/
10%
|
68%
|
42.0
↑
|
-0.13
|
0.07
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
26,683,637,760 |
Cash |
1,819,319,040 |
| Debt |
29,807,785,984 |
Recommendation |
hold |
| RSI |
42.0 |
MACD |
-0.57 |
| Signal |
-0.44 |
Histogram |
-0.13 |
| Revenue Growth |
2.0% |
EPS Growth |
-85.0% |
| Gross Margin |
53.0% |
ROE |
9.0% |
| Target Price |
73.58 |
Analysts |
12 |
|
|
9.0
|
ETR
|
Entergy Corporation
|
107.02
|
buy
|
6%
/
13%
|
70%
|
46.6
↑
|
0.18
|
0.09
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
49,346,281,472 |
Cash |
3,855,045,120 |
| Debt |
34,627,321,856 |
Recommendation |
buy |
| RSI |
46.6 |
MACD |
-0.94 |
| Signal |
-1.12 |
Histogram |
0.18 |
| Revenue Growth |
6.0% |
EPS Growth |
-2.0% |
| Gross Margin |
47.0% |
ROE |
10.0% |
| Target Price |
123.32 |
Analysts |
20 |
|
|
116.0
|
EVC
|
Entravision Communications Corp
|
8.03
|
none
|
126%
/
1%
|
53%
|
31.9
↑
|
-0.07
|
1.16
|
▼ |
| Sector |
Communication Services |
Industry |
Advertising Agencies |
| Market Cap |
744,766,592 |
Cash |
83,381,000 |
| Debt |
206,270,000 |
Recommendation |
none |
| RSI |
31.9 |
MACD |
-0.76 |
| Signal |
-0.69 |
Histogram |
-0.07 |
| Revenue Growth |
126.0% |
EPS Growth |
N/A |
| Gross Margin |
26.0% |
ROE |
6.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
6.0
|
EVRG
|
Evergy, Inc.
|
81.52
|
buy
|
4%
/
15%
|
69%
|
43.2
↑
|
-0.08
|
0.06
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
18,595,241,984 |
Cash |
21,800,000 |
| Debt |
16,497,999,872 |
Recommendation |
buy |
| RSI |
43.2 |
MACD |
-0.62 |
| Signal |
-0.54 |
Histogram |
-0.08 |
| Revenue Growth |
4.0% |
EPS Growth |
23.0% |
| Gross Margin |
53.0% |
ROE |
9.0% |
| Target Price |
91.95 |
Analysts |
11 |
|
|
61.0
|
EWTX
|
Edgewise Therapeutics, Inc.
|
42.25
|
buy
|
N/A
/
0%
|
82%
|
47.6
↑
|
-0.38
|
0.61
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
4,643,912,192 |
Cash |
460,708,992 |
| Debt |
3,590,000 |
Recommendation |
buy |
| RSI |
47.6 |
MACD |
0.51 |
| Signal |
0.89 |
Histogram |
-0.38 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-38.0% |
| Target Price |
51.69 |
Analysts |
13 |
|
|
-3.0
|
EXC
|
Exelon Corporation
|
43.83
|
hold
|
10%
/
11%
|
27%
|
37.3
↑
|
-0.11
|
-0.03
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
45,259,055,104 |
Cash |
1,812,999,936 |
| Debt |
52,672,999,424 |
Recommendation |
hold |
| RSI |
37.3 |
MACD |
-0.58 |
| Signal |
-0.47 |
Histogram |
-0.11 |
| Revenue Growth |
10.0% |
EPS Growth |
0.0% |
| Gross Margin |
42.0% |
ROE |
10.0% |
| Target Price |
48.88 |
Analysts |
17 |
|
|
61.0
|
FATE
|
Fate Therapeutics, Inc.
|
2.43
|
buy
|
9%
/
0%
|
69%
|
45.5
↑
|
-0.02
|
0.61
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
291,163,840 |
Cash |
153,770,000 |
| Debt |
75,675,000 |
Recommendation |
buy |
| RSI |
45.5 |
MACD |
-0.03 |
| Signal |
-0.02 |
Histogram |
-0.02 |
| Revenue Growth |
9.0% |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-61.0% |
| Target Price |
5.74 |
Analysts |
9 |
|
|
-6.0
|
FCN
|
FTI Consulting, Inc.
|
151.36
|
none
|
5%
/
6%
|
24%
|
44.1
↑
|
-0.12
|
-0.06
|
▼ |
| Sector |
Industrials |
Industry |
Consulting Services |
| Market Cap |
4,245,003,776 |
Cash |
188,947,008 |
| Debt |
1,267,516,032 |
Recommendation |
none |
| RSI |
44.1 |
MACD |
-1.31 |
| Signal |
-1.20 |
Histogram |
-0.12 |
| Revenue Growth |
5.0% |
EPS Growth |
-7.0% |
| Gross Margin |
32.0% |
ROE |
16.0% |
| Target Price |
175.50 |
Analysts |
2 |
|
|
2.0
|
FE
|
FirstEnergy Corp.
|
46.16
|
buy
|
9%
/
7%
|
50%
|
41.0
↑
|
-0.10
|
0.02
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
26,548,000,768 |
Cash |
63,000,000 |
| Debt |
28,982,999,040 |
Recommendation |
buy |
| RSI |
41.0 |
MACD |
-0.39 |
| Signal |
-0.29 |
Histogram |
-0.10 |
| Revenue Growth |
9.0% |
EPS Growth |
8.0% |
| Gross Margin |
69.0% |
ROE |
9.0% |
| Target Price |
53.17 |
Analysts |
12 |
|
|
-20.0
|
FIS
|
Fidelity National Information S
|
40.83
|
buy
|
29%
/
28%
|
11%
|
44.6
↑
|
-0.18
|
-0.20
|
▼ |
| Sector |
Technology |
Industry |
Information Technology Services |
| Market Cap |
21,370,853,376 |
Cash |
744,000,000 |
| Debt |
21,255,999,488 |
Recommendation |
buy |
| RSI |
44.6 |
MACD |
-0.48 |
| Signal |
-0.30 |
Histogram |
-0.18 |
| Revenue Growth |
29.0% |
EPS Growth |
N/A |
| Gross Margin |
36.0% |
ROE |
22.0% |
| Target Price |
50.35 |
Analysts |
23 |
|
|
33.0
|
FIX
|
Comfort Systems USA, Inc.
|
1554.37
|
strong_buy
|
1%
/
13%
|
63%
|
39.5
↑
|
-15.00
|
0.33
|
▼ |
| Sector |
Industrials |
Industry |
Engineering & Construction |
| Market Cap |
53,450,682,368 |
Cash |
70,540,000 |
| Debt |
303,920,992 |
Recommendation |
strong_buy |
| RSI |
39.5 |
MACD |
-46.82 |
| Signal |
-31.82 |
Histogram |
-15.00 |
| Revenue Growth |
1.0% |
EPS Growth |
39.0% |
| Gross Margin |
26.0% |
ROE |
55.0% |
| Target Price |
2197.00 |
Analysts |
8 |
|
|
-6.0
|
FIZZ
|
National Beverage Corp.
|
31.69
|
none
|
-5%
/
16%
|
39%
|
48.6
↑
|
-0.02
|
-0.06
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Beverages - Non-Alcoholic |
| Market Cap |
3,049,882,624 |
Cash |
349,543,008 |
| Debt |
58,936,000 |
Recommendation |
none |
| RSI |
48.6 |
MACD |
0.26 |
| Signal |
0.28 |
Histogram |
-0.02 |
| Revenue Growth |
-5.0% |
EPS Growth |
-8.0% |
| Gross Margin |
37.0% |
ROE |
34.0% |
| Target Price |
33.00 |
Analysts |
1 |
|
|
22.0
|
FMBH
|
First Mid Bancshares, Inc.
|
49.79
|
none
|
26%
/
27%
|
86%
|
43.4
↑
|
-0.28
|
0.22
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
1,339,140,224 |
Cash |
310,228,992 |
| Debt |
488,015,008 |
Recommendation |
none |
| RSI |
43.4 |
MACD |
0.00 |
| Signal |
0.29 |
Histogram |
-0.28 |
| Revenue Growth |
26.0% |
EPS Growth |
6.0% |
| Gross Margin |
0.0% |
ROE |
10.0% |
| Target Price |
56.50 |
Analysts |
7 |
|
|
9.0
|
FR
|
First Industrial Realty Trust,
|
62.43
|
buy
|
8%
/
48%
|
68%
|
41.4
↑
|
-0.06
|
0.09
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Industrial |
| Market Cap |
8,486,955,008 |
Cash |
46,052,000 |
| Debt |
2,584,134,912 |
Recommendation |
buy |
| RSI |
41.4 |
MACD |
-0.58 |
| Signal |
-0.52 |
Histogram |
-0.06 |
| Revenue Growth |
8.0% |
EPS Growth |
39.0% |
| Gross Margin |
74.0% |
ROE |
14.0% |
| Target Price |
71.94 |
Analysts |
16 |
|
|
10.0
|
FRT
|
Federal Realty Investment Trust
|
117.03
|
buy
|
7%
/
33%
|
71%
|
40.1
↑
|
-0.01
|
0.10
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
10,206,090,240 |
Cash |
115,276,000 |
| Debt |
4,851,821,056 |
Recommendation |
buy |
| RSI |
40.1 |
MACD |
-1.36 |
| Signal |
-1.35 |
Histogram |
-0.01 |
| Revenue Growth |
7.0% |
EPS Growth |
-46.0% |
| Gross Margin |
68.0% |
ROE |
13.0% |
| Target Price |
133.25 |
Analysts |
20 |
|
|
5.0
|
FSBW
|
FS Bancorp, Inc.
|
42.43
|
hold
|
2%
/
23%
|
70%
|
46.2
↑
|
-0.09
|
0.05
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
336,893,024 |
Cash |
34,744,000 |
| Debt |
381,035,008 |
Recommendation |
hold |
| RSI |
46.2 |
MACD |
-0.12 |
| Signal |
-0.03 |
Histogram |
-0.09 |
| Revenue Growth |
2.0% |
EPS Growth |
5.0% |
| Gross Margin |
0.0% |
ROE |
11.0% |
| Target Price |
45.00 |
Analysts |
2 |
|
|
-47.0
|
FSP
|
Franklin Street Properties Corp
|
0.40
|
none
|
-1%
/
-39%
|
0%
|
36.1
↑
|
-0.00
|
-0.47
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Office |
| Market Cap |
42,155,944 |
Cash |
22,459,000 |
| Debt |
254,059,008 |
Recommendation |
none |
| RSI |
36.1 |
MACD |
-0.02 |
| Signal |
-0.01 |
Histogram |
-0.00 |
| Revenue Growth |
-1.0% |
EPS Growth |
N/A |
| Gross Margin |
44.0% |
ROE |
-7.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
25.0
|
FVR
|
FrontView REIT, Inc.
|
19.40
|
buy
|
2%
/
2%
|
74%
|
40.4
↑
|
-0.03
|
0.25
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Diversified |
| Market Cap |
587,833,856 |
Cash |
8,543,000 |
| Debt |
329,104,000 |
Recommendation |
buy |
| RSI |
40.4 |
MACD |
-0.21 |
| Signal |
-0.18 |
Histogram |
-0.03 |
| Revenue Growth |
2.0% |
EPS Growth |
N/A |
| Gross Margin |
87.0% |
ROE |
0.0% |
| Target Price |
22.42 |
Analysts |
12 |
|
|
31.0
|
GEF
|
Greif Inc.
|
83.09
|
none
|
4%
/
25%
|
80%
|
45.8
↑
|
-1.07
|
0.31
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Packaging & Containers |
| Market Cap |
4,779,793,408 |
Cash |
288,500,000 |
| Debt |
1,233,600,000 |
Recommendation |
none |
| RSI |
45.8 |
MACD |
0.84 |
| Signal |
1.91 |
Histogram |
-1.07 |
| Revenue Growth |
4.0% |
EPS Growth |
43.0% |
| Gross Margin |
23.0% |
ROE |
N/A |
| Target Price |
87.20 |
Analysts |
5 |
|
|
-25.0
|
GILT
|
Gilat Satellite Networks Ltd.
|
10.06
|
none
|
17%
/
6%
|
6%
|
37.3
↑
|
-0.04
|
-0.25
|
▼ |
| Sector |
Technology |
Industry |
Communication Equipment |
| Market Cap |
765,674,752 |
Cash |
159,155,008 |
| Debt |
9,615,000 |
Recommendation |
none |
| RSI |
37.3 |
MACD |
-0.46 |
| Signal |
-0.41 |
Histogram |
-0.04 |
| Revenue Growth |
17.0% |
EPS Growth |
-42.0% |
| Gross Margin |
30.0% |
ROE |
7.0% |
| Target Price |
19.20 |
Analysts |
2 |
|
|
9.0
|
GLRE
|
Greenlight Reinsurance, Ltd.
|
15.26
|
none
|
-10%
/
7%
|
47%
|
40.6
↑
|
0.00
|
0.09
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Reinsurance |
| Market Cap |
501,697,440 |
Cash |
76,322,000 |
| Debt |
11,550,000 |
Recommendation |
none |
| RSI |
40.6 |
MACD |
-0.28 |
| Signal |
-0.28 |
Histogram |
0.00 |
| Revenue Growth |
-10.0% |
EPS Growth |
N/A |
| Gross Margin |
12.0% |
ROE |
7.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
-6.0
|
GLSI
|
Greenwich LifeSciences, Inc.
|
15.01
|
none
|
N/A
/
0%
|
28%
|
43.0
↑
|
0.04
|
-0.06
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
230,007,520 |
Cash |
8,876,353 |
| Debt |
0 |
Recommendation |
none |
| RSI |
43.0 |
MACD |
0.01 |
| Signal |
-0.04 |
Histogram |
0.04 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-986.0% |
| Target Price |
57.00 |
Analysts |
2 |
|
|
20.0
|
GLUE
|
Monte Rosa Therapeutics, Inc.
|
14.31
|
strong_buy
|
-61%
/
0%
|
46%
|
35.0
↑
|
0.10
|
0.20
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
1,141,493,248 |
Cash |
621,104,000 |
| Debt |
37,987,000 |
Recommendation |
strong_buy |
| RSI |
35.0 |
MACD |
-1.47 |
| Signal |
-1.57 |
Histogram |
0.10 |
| Revenue Growth |
-61.0% |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-43.0% |
| Target Price |
28.50 |
Analysts |
6 |
|
|
-15.0
|
GME
|
GameStop Corporation
|
18.81
|
none
|
14%
/
20%
|
10%
|
46.6
↑
|
0.15
|
-0.15
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Specialty Retail |
| Market Cap |
8,018,113,024 |
Cash |
8,368,099,840 |
| Debt |
4,339,100,160 |
Recommendation |
none |
| RSI |
46.6 |
MACD |
-0.62 |
| Signal |
-0.77 |
Histogram |
0.15 |
| Revenue Growth |
14.0% |
EPS Growth |
633.0% |
| Gross Margin |
34.0% |
ROE |
14.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
-54.0
|
GOGO
|
Gogo Inc.
|
2.55
|
none
|
-1%
/
0%
|
0%
|
35.2
↑
|
-0.02
|
-0.54
|
▼ |
| Sector |
Communication Services |
Industry |
Telecom Services |
| Market Cap |
368,581,376 |
Cash |
66,347,000 |
| Debt |
880,640,000 |
Recommendation |
none |
| RSI |
35.2 |
MACD |
-0.28 |
| Signal |
-0.27 |
Histogram |
-0.02 |
| Revenue Growth |
-1.0% |
EPS Growth |
N/A |
| Gross Margin |
42.0% |
ROE |
-1.0% |
| Target Price |
8.50 |
Analysts |
2 |
|
|
15.0
|
GPRE
|
Green Plains, Inc.
|
14.75
|
buy
|
-19%
/
7%
|
57%
|
42.9
↑
|
-0.13
|
0.15
|
▼ |
| Sector |
Basic Materials |
Industry |
Chemicals |
| Market Cap |
1,027,597,504 |
Cash |
185,384,000 |
| Debt |
548,633,984 |
Recommendation |
buy |
| RSI |
42.9 |
MACD |
-0.44 |
| Signal |
-0.32 |
Histogram |
-0.13 |
| Revenue Growth |
-19.0% |
EPS Growth |
N/A |
| Gross Margin |
16.0% |
ROE |
15.0% |
| Target Price |
17.86 |
Analysts |
7 |
|
|
21.0
|
GRND
|
Grindr Inc.
|
15.53
|
buy
|
32%
/
19%
|
70%
|
45.9
↑
|
-0.12
|
0.21
|
▼ |
| Sector |
Technology |
Industry |
Software - Application |
| Market Cap |
2,709,863,680 |
Cash |
6,504,000 |
| Debt |
389,595,008 |
Recommendation |
buy |
| RSI |
45.9 |
MACD |
-0.08 |
| Signal |
0.03 |
Histogram |
-0.12 |
| Revenue Growth |
32.0% |
EPS Growth |
25.0% |
| Gross Margin |
75.0% |
ROE |
109.0% |
| Target Price |
20.80 |
Analysts |
5 |
|
|
-8.0
|
HCAT
|
Health Catalyst, Inc
|
1.71
|
hold
|
-13%
/
-91%
|
29%
|
44.9
↑
|
-0.00
|
-0.08
|
▼ |
| Sector |
Healthcare |
Industry |
Health Information Services |
| Market Cap |
119,657,656 |
Cash |
103,439,000 |
| Debt |
169,976,992 |
Recommendation |
hold |
| RSI |
44.9 |
MACD |
-0.11 |
| Signal |
-0.11 |
Histogram |
-0.00 |
| Revenue Growth |
-13.0% |
EPS Growth |
N/A |
| Gross Margin |
51.0% |
ROE |
-118.0% |
| Target Price |
1.82 |
Analysts |
4 |
|
|
-6.0
|
HII
|
Huntington Ingalls Industries,
|
292.42
|
buy
|
11%
/
5%
|
16%
|
41.6
↑
|
-3.54
|
-0.06
|
▼ |
| Sector |
Industrials |
Industry |
Aerospace & Defense |
| Market Cap |
11,593,227,264 |
Cash |
12,000,000 |
| Debt |
2,935,000,064 |
Recommendation |
buy |
| RSI |
41.6 |
MACD |
-2.56 |
| Signal |
0.98 |
Histogram |
-3.54 |
| Revenue Growth |
11.0% |
EPS Growth |
36.0% |
| Gross Margin |
12.0% |
ROE |
13.0% |
| Target Price |
368.42 |
Analysts |
12 |
|
|
-9.0
|
HLF
|
Herbalife Ltd.
|
11.52
|
none
|
5%
/
3%
|
31%
|
43.4
↑
|
-0.08
|
-0.09
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Packaged Foods |
| Market Cap |
1,288,610,816 |
Cash |
370,500,000 |
| Debt |
2,203,800,064 |
Recommendation |
none |
| RSI |
43.4 |
MACD |
-0.12 |
| Signal |
-0.04 |
Histogram |
-0.08 |
| Revenue Growth |
5.0% |
EPS Growth |
N/A |
| Gross Margin |
78.0% |
ROE |
N/A |
| Target Price |
17.00 |
Analysts |
3 |
|
|
-14.0
|
HLLY
|
Holley Inc.
|
2.87
|
buy
|
3%
/
2%
|
25%
|
47.8
↑
|
-0.04
|
-0.14
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Auto Parts |
| Market Cap |
354,003,712 |
Cash |
69,020,000 |
| Debt |
570,104,000 |
Recommendation |
buy |
| RSI |
47.8 |
MACD |
0.04 |
| Signal |
0.08 |
Histogram |
-0.04 |
| Revenue Growth |
3.0% |
EPS Growth |
N/A |
| Gross Margin |
43.0% |
ROE |
2.0% |
| Target Price |
4.58 |
Analysts |
7 |
|
|
8.0
|
HPP
|
Hudson Pacific Properties, Inc.
|
12.79
|
buy
|
-1%
/
-68%
|
46%
|
39.6
↑
|
-0.15
|
0.08
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Office |
| Market Cap |
1,456,843,904 |
Cash |
84,044,000 |
| Debt |
3,738,608,128 |
Recommendation |
buy |
| RSI |
39.6 |
MACD |
-0.28 |
| Signal |
-0.13 |
Histogram |
-0.15 |
| Revenue Growth |
-1.0% |
EPS Growth |
N/A |
| Gross Margin |
49.0% |
ROE |
-17.0% |
| Target Price |
17.00 |
Analysts |
11 |
|
|
6.0
|
HQY
|
HealthEquity, Inc.
|
97.00
|
strong_buy
|
7%
/
17%
|
71%
|
41.4
↑
|
-1.41
|
0.06
|
▼ |
| Sector |
Healthcare |
Industry |
Health Information Services |
| Market Cap |
7,971,273,216 |
Cash |
265,368,992 |
| Debt |
984,681,984 |
Recommendation |
strong_buy |
| RSI |
41.4 |
MACD |
-0.06 |
| Signal |
1.35 |
Histogram |
-1.41 |
| Revenue Growth |
7.0% |
EPS Growth |
34.0% |
| Gross Margin |
71.0% |
ROE |
11.0% |
| Target Price |
118.53 |
Analysts |
15 |
|
|
7.0
|
HR
|
Healthcare Realty Trust Incorpo
|
19.36
|
hold
|
-4%
/
-8%
|
62%
|
43.0
↑
|
0.02
|
0.07
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Healthcare Facilities |
| Market Cap |
6,589,488,128 |
Cash |
24,670,000 |
| Debt |
4,402,505,216 |
Recommendation |
hold |
| RSI |
43.0 |
MACD |
-0.29 |
| Signal |
-0.31 |
Histogram |
0.02 |
| Revenue Growth |
-4.0% |
EPS Growth |
N/A |
| Gross Margin |
62.0% |
ROE |
-2.0% |
| Target Price |
21.58 |
Analysts |
12 |
|
|
-6.0
|
HRL
|
Hormel Foods Corporation
|
21.99
|
hold
|
-3%
/
3%
|
37%
|
31.2
↑
|
-0.30
|
-0.06
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Packaged Foods |
| Market Cap |
11,870,292,992 |
Cash |
574,262,976 |
| Debt |
250,000,000 |
Recommendation |
hold |
| RSI |
31.2 |
MACD |
-0.67 |
| Signal |
-0.37 |
Histogram |
-0.30 |
| Revenue Growth |
-3.0% |
EPS Growth |
-5.0% |
| Gross Margin |
16.0% |
ROE |
4.0% |
| Target Price |
27.25 |
Analysts |
8 |
|
|
-5.0
|
HROW
|
Harrow, Inc.
|
36.97
|
strong_buy
|
11%
/
-14%
|
31%
|
38.8
↑
|
-0.32
|
-0.05
|
▼ |
| Sector |
Healthcare |
Industry |
Drug Manufacturers - Specialty & Generic |
| Market Cap |
1,397,172,096 |
Cash |
85,317,000 |
| Debt |
300,744,000 |
Recommendation |
strong_buy |
| RSI |
38.8 |
MACD |
-0.60 |
| Signal |
-0.28 |
Histogram |
-0.32 |
| Revenue Growth |
11.0% |
EPS Growth |
N/A |
| Gross Margin |
73.0% |
ROE |
-116.0% |
| Target Price |
67.50 |
Analysts |
8 |
|
|
-17.0
|
HWKN
|
Hawkins, Inc.
|
124.58
|
buy
|
-2%
/
7%
|
11%
|
44.6
↑
|
0.27
|
-0.17
|
▼ |
| Sector |
Basic Materials |
Industry |
Specialty Chemicals |
| Market Cap |
2,512,320,256 |
Cash |
5,607,000 |
| Debt |
94,502,000 |
Recommendation |
buy |
| RSI |
44.6 |
MACD |
-4.76 |
| Signal |
-5.03 |
Histogram |
0.27 |
| Revenue Growth |
-2.0% |
EPS Growth |
8.0% |
| Gross Margin |
22.0% |
ROE |
16.0% |
| Target Price |
174.25 |
Analysts |
4 |
|
|
13.0
|
HWM
|
Howmet Aerospace Inc.
|
254.89
|
strong_buy
|
24%
/
21%
|
68%
|
37.4
↑
|
-3.70
|
0.13
|
▼ |
| Sector |
Industrials |
Industry |
Aerospace & Defense |
| Market Cap |
105,622,552,576 |
Cash |
563,000,000 |
| Debt |
4,664,000,000 |
Recommendation |
strong_buy |
| RSI |
37.4 |
MACD |
-5.79 |
| Signal |
-2.08 |
Histogram |
-3.70 |
| Revenue Growth |
24.0% |
EPS Growth |
33.0% |
| Gross Margin |
36.0% |
ROE |
35.0% |
| Target Price |
337.13 |
Analysts |
20 |
|
|
4.0
|
IDA
|
IDACORP, Inc.
|
136.39
|
buy
|
4%
/
19%
|
48%
|
35.5
↑
|
-0.28
|
0.04
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
7,853,792,768 |
Cash |
83,644,000 |
| Debt |
4,007,785,984 |
Recommendation |
buy |
| RSI |
35.5 |
MACD |
-2.06 |
| Signal |
-1.78 |
Histogram |
-0.28 |
| Revenue Growth |
4.0% |
EPS Growth |
2.0% |
| Gross Margin |
39.0% |
ROE |
9.0% |
| Target Price |
158.22 |
Analysts |
9 |
|
|
25.0
|
INBK
|
First Internet Bancorp
|
27.50
|
none
|
39%
/
-57%
|
81%
|
43.9
↑
|
-0.29
|
0.25
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
244,627,408 |
Cash |
411,087,008 |
| Debt |
345,244,992 |
Recommendation |
none |
| RSI |
43.9 |
MACD |
0.00 |
| Signal |
0.29 |
Histogram |
-0.29 |
| Revenue Growth |
39.0% |
EPS Growth |
1,250.0% |
| Gross Margin |
0.0% |
ROE |
-8.0% |
| Target Price |
30.90 |
Analysts |
5 |
|
|
84.0
|
INNV
|
InnovAge Holding Corp.
|
10.83
|
hold
|
16%
/
-1%
|
85%
|
48.3
↑
|
-0.01
|
0.84
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
1,474,097,280 |
Cash |
138,588,000 |
| Debt |
93,846,000 |
Recommendation |
hold |
| RSI |
48.3 |
MACD |
-0.02 |
| Signal |
-0.01 |
Histogram |
-0.01 |
| Revenue Growth |
16.0% |
EPS Growth |
N/A |
| Gross Margin |
68.0% |
ROE |
-6.0% |
| Target Price |
10.00 |
Analysts |
2 |
|
|
-3.0
|
INVA
|
Innoviva, Inc.
|
21.08
|
buy
|
19%
/
81%
|
58%
|
48.5
↑
|
0.04
|
-0.03
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
1,514,987,776 |
Cash |
579,056,000 |
| Debt |
331,239,008 |
Recommendation |
buy |
| RSI |
48.5 |
MACD |
-0.12 |
| Signal |
-0.16 |
Histogram |
0.04 |
| Revenue Growth |
19.0% |
EPS Growth |
N/A |
| Gross Margin |
73.0% |
ROE |
37.0% |
| Target Price |
35.00 |
Analysts |
4 |
|
|
10.0
|
IRON
|
Disc Medicine, Inc.
|
78.67
|
strong_buy
|
N/A
/
0%
|
60%
|
49.3
↑
|
-0.26
|
0.10
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
3,072,579,328 |
Cash |
717,745,984 |
| Debt |
60,862,000 |
Recommendation |
strong_buy |
| RSI |
49.3 |
MACD |
1.13 |
| Signal |
1.39 |
Histogram |
-0.26 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-39.0% |
| Target Price |
101.58 |
Analysts |
12 |
|
|
0.0
|
IRT
|
Independence Realty Trust, Inc.
|
16.27
|
buy
|
3%
/
6%
|
61%
|
42.3
↑
|
-0.06
|
0.00
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Residential |
| Market Cap |
3,941,901,824 |
Cash |
37,363,000 |
| Debt |
2,446,127,104 |
Recommendation |
buy |
| RSI |
42.3 |
MACD |
-0.09 |
| Signal |
-0.02 |
Histogram |
-0.06 |
| Revenue Growth |
3.0% |
EPS Growth |
-67.0% |
| Gross Margin |
61.0% |
ROE |
1.0% |
| Target Price |
19.50 |
Analysts |
14 |
|
|
8.0
|
IVT
|
InvenTrust Properties Corp.
|
32.53
|
buy
|
13%
/
5%
|
58%
|
33.8
↑
|
-0.03
|
0.08
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
2,538,198,016 |
Cash |
84,232,000 |
| Debt |
1,096,717,056 |
Recommendation |
buy |
| RSI |
33.8 |
MACD |
-0.60 |
| Signal |
-0.57 |
Histogram |
-0.03 |
| Revenue Growth |
13.0% |
EPS Growth |
-99.0% |
| Gross Margin |
73.0% |
ROE |
1.0% |
| Target Price |
37.43 |
Analysts |
7 |
|
|
5.0
|
JBSS
|
John B. Sanfilippo & Son, Inc.
|
73.88
|
strong_buy
|
4%
/
5%
|
55%
|
35.6
↑
|
-0.82
|
0.05
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Packaged Foods |
| Market Cap |
872,743,744 |
Cash |
1,147,000 |
| Debt |
109,347,000 |
Recommendation |
strong_buy |
| RSI |
35.6 |
MACD |
-2.01 |
| Signal |
-1.19 |
Histogram |
-0.82 |
| Revenue Growth |
4.0% |
EPS Growth |
-38.0% |
| Gross Margin |
18.0% |
ROE |
17.0% |
| Target Price |
100.00 |
Analysts |
2 |
|
|
-20.0
|
JRVR
|
James River Group Holdings, Inc
|
4.02
|
hold
|
-8%
/
5%
|
6%
|
37.3
↑
|
-0.01
|
-0.20
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Specialty |
| Market Cap |
191,429,584 |
Cash |
199,612,992 |
| Debt |
329,855,008 |
Recommendation |
hold |
| RSI |
37.3 |
MACD |
-0.12 |
| Signal |
-0.10 |
Histogram |
-0.01 |
| Revenue Growth |
-8.0% |
EPS Growth |
57.0% |
| Gross Margin |
35.0% |
ROE |
5.0% |
| Target Price |
4.72 |
Analysts |
2 |
|
|
39.0
|
KALU
|
Kaiser Aluminum Corporation
|
163.31
|
none
|
53%
/
5%
|
74%
|
48.2
↑
|
-1.09
|
0.39
|
▼ |
| Sector |
Basic Materials |
Industry |
Aluminum |
| Market Cap |
2,556,670,976 |
Cash |
58,500,000 |
| Debt |
1,068,899,968 |
Recommendation |
none |
| RSI |
48.2 |
MACD |
-3.82 |
| Signal |
-2.72 |
Histogram |
-1.09 |
| Revenue Growth |
53.0% |
EPS Growth |
306.0% |
| Gross Margin |
15.0% |
ROE |
26.0% |
| Target Price |
169.25 |
Analysts |
4 |
|
|
-11.0
|
KE
|
Kimball Electronics, Inc.
|
23.90
|
strong_buy
|
-2%
/
2%
|
12%
|
45.5
↑
|
-0.12
|
-0.11
|
▼ |
| Sector |
Industrials |
Industry |
Electrical Equipment & Parts |
| Market Cap |
564,187,712 |
Cash |
88,925,000 |
| Debt |
133,072,000 |
Recommendation |
strong_buy |
| RSI |
45.5 |
MACD |
-0.42 |
| Signal |
-0.31 |
Histogram |
-0.12 |
| Revenue Growth |
-2.0% |
EPS Growth |
31.0% |
| Gross Margin |
8.0% |
ROE |
5.0% |
| Target Price |
34.25 |
Analysts |
4 |
|
|
-47.0
|
KG
|
Kestrel Group, Ltd.
|
7.61
|
none
|
20%
/
-86%
|
2%
|
41.7
↑
|
0.00
|
-0.47
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Reinsurance |
| Market Cap |
59,227,908 |
Cash |
16,062,000 |
| Debt |
176,994,000 |
Recommendation |
none |
| RSI |
41.7 |
MACD |
-0.48 |
| Signal |
-0.49 |
Histogram |
0.00 |
| Revenue Growth |
20.0% |
EPS Growth |
N/A |
| Gross Margin |
46.0% |
ROE |
-27.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
28.0
|
KGS
|
Kodiak Gas Services, Inc.
|
59.55
|
strong_buy
|
21%
/
6%
|
63%
|
45.7
↑
|
-0.00
|
0.28
|
▼ |
| Sector |
Energy |
Industry |
Oil & Gas Equipment & Services |
| Market Cap |
5,830,669,312 |
Cash |
137,552,992 |
| Debt |
2,819,315,968 |
Recommendation |
strong_buy |
| RSI |
45.7 |
MACD |
-0.83 |
| Signal |
-0.83 |
Histogram |
-0.00 |
| Revenue Growth |
21.0% |
EPS Growth |
23.0% |
| Gross Margin |
64.0% |
ROE |
5.0% |
| Target Price |
83.13 |
Analysts |
15 |
|
|
9.0
|
KIM
|
Kimco Realty Corporation (HC)
|
24.12
|
buy
|
5%
/
28%
|
69%
|
43.0
↑
|
-0.01
|
0.09
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
15,951,372,288 |
Cash |
702,396,032 |
| Debt |
8,858,840,064 |
Recommendation |
buy |
| RSI |
43.0 |
MACD |
-0.32 |
| Signal |
-0.31 |
Histogram |
-0.01 |
| Revenue Growth |
5.0% |
EPS Growth |
-6.0% |
| Gross Margin |
69.0% |
ROE |
6.0% |
| Target Price |
27.01 |
Analysts |
22 |
|
|
25.0
|
KN
|
Knowles Corporation
|
34.33
|
none
|
14%
/
11%
|
62%
|
42.6
↑
|
-0.23
|
0.25
|
▼ |
| Sector |
Technology |
Industry |
Electronic Components |
| Market Cap |
2,923,595,520 |
Cash |
49,600,000 |
| Debt |
150,200,000 |
Recommendation |
none |
| RSI |
42.6 |
MACD |
-0.96 |
| Signal |
-0.73 |
Histogram |
-0.23 |
| Revenue Growth |
14.0% |
EPS Growth |
147.0% |
| Gross Margin |
45.0% |
ROE |
9.0% |
| Target Price |
43.75 |
Analysts |
4 |
|
|
34.0
|
KOP
|
Koppers Holdings Inc.
|
45.93
|
none
|
3%
/
-5%
|
76%
|
44.6
↑
|
-0.13
|
0.34
|
▼ |
| Sector |
Basic Materials |
Industry |
Specialty Chemicals |
| Market Cap |
880,522,624 |
Cash |
41,400,000 |
| Debt |
1,003,500,032 |
Recommendation |
none |
| RSI |
44.6 |
MACD |
-0.63 |
| Signal |
-0.51 |
Histogram |
-0.13 |
| Revenue Growth |
3.0% |
EPS Growth |
N/A |
| Gross Margin |
22.0% |
ROE |
-19.0% |
| Target Price |
57.00 |
Analysts |
3 |
|
|
7.0
|
KRG
|
Kite Realty Group Trust
|
26.12
|
buy
|
-8%
/
42%
|
60%
|
36.5
↑
|
0.01
|
0.07
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
5,335,109,632 |
Cash |
144,708,000 |
| Debt |
2,906,885,888 |
Recommendation |
buy |
| RSI |
36.5 |
MACD |
-0.52 |
| Signal |
-0.54 |
Histogram |
0.01 |
| Revenue Growth |
-8.0% |
EPS Growth |
58.0% |
| Gross Margin |
73.0% |
ROE |
11.0% |
| Target Price |
31.00 |
Analysts |
10 |
|
|
4.0
|
L
|
Loews Corporation
|
108.71
|
none
|
4%
/
9%
|
55%
|
32.9
↑
|
-0.44
|
0.04
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Property & Casualty |
| Market Cap |
22,429,808,640 |
Cash |
6,397,000,192 |
| Debt |
8,935,999,488 |
Recommendation |
none |
| RSI |
32.9 |
MACD |
-1.39 |
| Signal |
-0.95 |
Histogram |
-0.44 |
| Revenue Growth |
4.0% |
EPS Growth |
16.0% |
| Gross Margin |
36.0% |
ROE |
9.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
12.0
|
LAMR
|
Lamar Advertising Company
|
151.08
|
hold
|
6%
/
24%
|
75%
|
42.5
↑
|
-0.36
|
0.12
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Specialty |
| Market Cap |
15,271,041,024 |
Cash |
67,950,000 |
| Debt |
4,978,484,224 |
Recommendation |
hold |
| RSI |
42.5 |
MACD |
-1.88 |
| Signal |
-1.52 |
Histogram |
-0.36 |
| Revenue Growth |
6.0% |
EPS Growth |
4.0% |
| Gross Margin |
67.0% |
ROE |
59.0% |
| Target Price |
162.20 |
Analysts |
5 |
|
|
4.0
|
LBRT
|
Liberty Energy Inc.
|
20.10
|
buy
|
14%
/
3%
|
43%
|
47.6
↑
|
0.11
|
0.04
|
▼ |
| Sector |
Energy |
Industry |
Oil & Gas Equipment & Services |
| Market Cap |
3,103,900,928 |
Cash |
555,358,976 |
| Debt |
1,613,101,056 |
Recommendation |
buy |
| RSI |
47.6 |
MACD |
-0.71 |
| Signal |
-0.82 |
Histogram |
0.11 |
| Revenue Growth |
14.0% |
EPS Growth |
-40.0% |
| Gross Margin |
19.0% |
ROE |
6.0% |
| Target Price |
29.04 |
Analysts |
13 |
|
|
-8.0
|
LCII
|
LCI Industries
|
100.77
|
none
|
-12%
/
5%
|
27%
|
43.9
↑
|
-0.55
|
-0.08
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Recreational Vehicles |
| Market Cap |
2,503,112,960 |
Cash |
216,512,000 |
| Debt |
1,146,180,992 |
Recommendation |
none |
| RSI |
43.9 |
MACD |
-0.40 |
| Signal |
0.15 |
Histogram |
-0.55 |
| Revenue Growth |
-12.0% |
EPS Growth |
20.0% |
| Gross Margin |
26.0% |
ROE |
15.0% |
| Target Price |
129.40 |
Analysts |
10 |
|
|
2.0
|
LEA
|
Lear Corporation
|
125.17
|
buy
|
3%
/
2%
|
56%
|
45.3
↑
|
0.58
|
0.02
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Auto Parts |
| Market Cap |
8,256,602,112 |
Cash |
1,006,700,032 |
| Debt |
3,515,699,968 |
Recommendation |
buy |
| RSI |
45.3 |
MACD |
-2.43 |
| Signal |
-3.02 |
Histogram |
0.58 |
| Revenue Growth |
3.0% |
EPS Growth |
24.0% |
| Gross Margin |
8.0% |
ROE |
12.0% |
| Target Price |
150.50 |
Analysts |
14 |
|
|
-26.0
|
LFMD
|
LifeMD, Inc.
|
3.10
|
none
|
-4%
/
0%
|
11%
|
36.4
↑
|
0.01
|
-0.26
|
▼ |
| Sector |
Healthcare |
Industry |
Health Information Services |
| Market Cap |
151,350,624 |
Cash |
25,141,616 |
| Debt |
6,017,124 |
Recommendation |
none |
| RSI |
36.4 |
MACD |
-0.21 |
| Signal |
-0.22 |
Histogram |
0.01 |
| Revenue Growth |
-4.0% |
EPS Growth |
N/A |
| Gross Margin |
88.0% |
ROE |
-516.0% |
| Target Price |
8.12 |
Analysts |
8 |
|
|
39.0
|
LGND
|
Ligand Pharmaceuticals Incorpor
|
284.27
|
strong_buy
|
34%
/
68%
|
76%
|
45.0
↑
|
-0.76
|
0.39
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
5,591,738,368 |
Cash |
1,357,757,952 |
| Debt |
1,131,453,056 |
Recommendation |
strong_buy |
| RSI |
45.0 |
MACD |
-2.67 |
| Signal |
-1.91 |
Histogram |
-0.76 |
| Revenue Growth |
34.0% |
EPS Growth |
825.0% |
| Gross Margin |
81.0% |
ROE |
22.0% |
| Target Price |
342.82 |
Analysts |
11 |
|
|
-12.0
|
LMAT
|
LeMaitre Vascular, Inc.
|
81.08
|
buy
|
10%
/
25%
|
6%
|
38.9
↑
|
0.31
|
-0.12
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Instruments & Supplies |
| Market Cap |
1,839,831,552 |
Cash |
376,240,000 |
| Debt |
190,254,000 |
Recommendation |
buy |
| RSI |
38.9 |
MACD |
-3.81 |
| Signal |
-4.12 |
Histogram |
0.31 |
| Revenue Growth |
10.0% |
EPS Growth |
23.0% |
| Gross Margin |
72.0% |
ROE |
17.0% |
| Target Price |
107.00 |
Analysts |
7 |
|
|
-47.0
|
LMB
|
Limbach Holdings, Inc.
|
44.79
|
buy
|
22%
/
4%
|
5%
|
36.1
↑
|
0.84
|
-0.47
|
▼ |
| Sector |
Industrials |
Industry |
Building Products & Equipment |
| Market Cap |
492,979,200 |
Cash |
17,529,000 |
| Debt |
59,586,000 |
Recommendation |
buy |
| RSI |
36.1 |
MACD |
-6.52 |
| Signal |
-7.37 |
Histogram |
0.84 |
| Revenue Growth |
22.0% |
EPS Growth |
-39.0% |
| Gross Margin |
24.0% |
ROE |
16.0% |
| Target Price |
76.20 |
Analysts |
5 |
|
|
17.0
|
LNC
|
Lincoln National Corporation
|
42.77
|
hold
|
13%
/
12%
|
72%
|
47.9
↑
|
-0.38
|
0.17
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Life |
| Market Cap |
8,287,754,752 |
Cash |
45,548,998,656 |
| Debt |
7,240,999,936 |
Recommendation |
hold |
| RSI |
47.9 |
MACD |
0.10 |
| Signal |
0.49 |
Histogram |
-0.38 |
| Revenue Growth |
13.0% |
EPS Growth |
77.0% |
| Gross Margin |
27.0% |
ROE |
23.0% |
| Target Price |
47.92 |
Analysts |
12 |
|
|
2.0
|
LRMR
|
Larimar Therapeutics, Inc.
|
3.94
|
none
|
N/A
/
0%
|
36%
|
46.8
↑
|
-0.05
|
0.02
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
416,570,592 |
Cash |
156,267,008 |
| Debt |
4,956,000 |
Recommendation |
none |
| RSI |
46.8 |
MACD |
0.02 |
| Signal |
0.08 |
Histogram |
-0.05 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-140.0% |
| Target Price |
14.30 |
Analysts |
10 |
|
|
-22.0
|
LVS
|
Las Vegas Sands Corp.
|
43.84
|
buy
|
-1%
/
13%
|
0%
|
36.5
↑
|
-0.23
|
-0.22
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Resorts & Casinos |
| Market Cap |
29,172,461,568 |
Cash |
3,376,000,000 |
| Debt |
15,283,999,744 |
Recommendation |
buy |
| RSI |
36.5 |
MACD |
-0.49 |
| Signal |
-0.26 |
Histogram |
-0.23 |
| Revenue Growth |
-1.0% |
EPS Growth |
-20.0% |
| Gross Margin |
79.0% |
ROE |
123.0% |
| Target Price |
59.07 |
Analysts |
19 |
|
|
-1.0
|
MAA
|
Mid-America Apartment Communiti
|
129.36
|
hold
|
1%
/
18%
|
51%
|
41.5
↑
|
-0.31
|
-0.01
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Residential |
| Market Cap |
15,418,897,408 |
Cash |
51,836,000 |
| Debt |
5,715,268,096 |
Recommendation |
hold |
| RSI |
41.5 |
MACD |
-1.04 |
| Signal |
-0.73 |
Histogram |
-0.31 |
| Revenue Growth |
1.0% |
EPS Growth |
14.0% |
| Gross Margin |
58.0% |
ROE |
7.0% |
| Target Price |
143.84 |
Analysts |
25 |
|
|
0.0
|
MDLN
|
Medline Inc.
|
35.11
|
buy
|
12%
/
2%
|
15%
|
46.3
↑
|
0.17
|
N/A
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Instruments & Supplies |
| Market Cap |
47,466,881,024 |
Cash |
2,700,000,000 |
| Debt |
12,640,000,000 |
Recommendation |
buy |
| RSI |
46.3 |
MACD |
-0.89 |
| Signal |
-1.06 |
Histogram |
0.17 |
| Revenue Growth |
12.0% |
EPS Growth |
262.0% |
| Gross Margin |
25.0% |
ROE |
5.0% |
| Target Price |
44.62 |
Analysts |
26 |
|
|
3.0
|
MDU
|
MDU Resources Group, Inc.
|
19.95
|
none
|
7%
/
11%
|
62%
|
40.6
↑
|
-0.02
|
0.03
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Gas |
| Market Cap |
4,162,816,000 |
Cash |
46,269,000 |
| Debt |
2,577,157,120 |
Recommendation |
none |
| RSI |
40.6 |
MACD |
-0.18 |
| Signal |
-0.17 |
Histogram |
-0.02 |
| Revenue Growth |
7.0% |
EPS Growth |
47.0% |
| Gross Margin |
35.0% |
ROE |
7.0% |
| Target Price |
23.62 |
Analysts |
8 |
|
|
-20.0
|
MDWD
|
MediWound Ltd.
|
12.62
|
strong_buy
|
-46%
/
-170%
|
0%
|
34.0
↑
|
-0.07
|
-0.20
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
163,444,112 |
Cash |
35,341,000 |
| Debt |
8,605,000 |
Recommendation |
strong_buy |
| RSI |
34.0 |
MACD |
-0.41 |
| Signal |
-0.34 |
Histogram |
-0.07 |
| Revenue Growth |
-46.0% |
EPS Growth |
N/A |
| Gross Margin |
15.0% |
ROE |
-72.0% |
| Target Price |
29.83 |
Analysts |
6 |
|
|
-4.0
|
MIDD
|
The Middleby Corporation
|
111.60
|
buy
|
10%
/
-14%
|
40%
|
32.0
↑
|
-0.32
|
-0.04
|
▼ |
| Sector |
Industrials |
Industry |
Specialty Industrial Machinery |
| Market Cap |
5,098,819,584 |
Cash |
161,099,008 |
| Debt |
2,000,348,032 |
Recommendation |
buy |
| RSI |
32.0 |
MACD |
-5.11 |
| Signal |
-4.78 |
Histogram |
-0.32 |
| Revenue Growth |
10.0% |
EPS Growth |
-39.0% |
| Gross Margin |
38.0% |
ROE |
11.0% |
| Target Price |
154.89 |
Analysts |
9 |
|
|
16.0
|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
98.34
|
strong_buy
|
38%
/
-139%
|
53%
|
42.2
↑
|
0.42
|
0.16
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
5,943,230,464 |
Cash |
438,291,008 |
| Debt |
762,948,992 |
Recommendation |
strong_buy |
| RSI |
42.2 |
MACD |
-2.88 |
| Signal |
-3.31 |
Histogram |
0.42 |
| Revenue Growth |
38.0% |
EPS Growth |
N/A |
| Gross Margin |
82.0% |
ROE |
-703.0% |
| Target Price |
138.21 |
Analysts |
14 |
|
|
-3.0
|
MLP
|
Maui Land & Pineapple Company,
|
16.11
|
none
|
-20%
/
-29%
|
34%
|
47.2
↑
|
0.04
|
-0.03
|
▼ |
| Sector |
Real Estate |
Industry |
Real Estate Services |
| Market Cap |
312,980,288 |
Cash |
3,282,000 |
| Debt |
9,300,000 |
Recommendation |
none |
| RSI |
47.2 |
MACD |
-0.29 |
| Signal |
-0.33 |
Histogram |
0.04 |
| Revenue Growth |
-20.0% |
EPS Growth |
N/A |
| Gross Margin |
27.0% |
ROE |
-16.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
0.0
|
MNTK
|
Montauk Renewables, Inc.
|
1.76
|
none
|
20%
/
4%
|
47%
|
47.5
↑
|
-0.02
|
0.00
|
▼ |
| Sector |
Basic Materials |
Industry |
Specialty Chemicals |
| Market Cap |
251,943,808 |
Cash |
15,757,000 |
| Debt |
157,135,008 |
Recommendation |
none |
| RSI |
47.5 |
MACD |
0.02 |
| Signal |
0.03 |
Histogram |
-0.02 |
| Revenue Growth |
20.0% |
EPS Growth |
N/A |
| Gross Margin |
35.0% |
ROE |
3.0% |
| Target Price |
1.70 |
Analysts |
3 |
|
|
-10.0
|
MOD
|
Modine Manufacturing Company
|
180.91
|
strong_buy
|
28%
/
4%
|
33%
|
37.1
↑
|
-0.20
|
-0.10
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Auto Parts |
| Market Cap |
9,434,411,008 |
Cash |
95,300,000 |
| Debt |
671,400,000 |
Recommendation |
strong_buy |
| RSI |
37.1 |
MACD |
-10.37 |
| Signal |
-10.17 |
Histogram |
-0.20 |
| Revenue Growth |
28.0% |
EPS Growth |
44.0% |
| Gross Margin |
22.0% |
ROE |
13.0% |
| Target Price |
310.29 |
Analysts |
7 |
|
|
37.0
|
MOV
|
Movado Group Inc.
|
33.96
|
strong_buy
|
5%
/
6%
|
75%
|
33.7
↑
|
-0.20
|
0.37
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Luxury Goods |
| Market Cap |
769,326,144 |
Cash |
212,100,992 |
| Debt |
68,109,000 |
Recommendation |
strong_buy |
| RSI |
33.7 |
MACD |
-0.88 |
| Signal |
-0.68 |
Histogram |
-0.20 |
| Revenue Growth |
5.0% |
EPS Growth |
308.0% |
| Gross Margin |
56.0% |
ROE |
8.0% |
| Target Price |
47.50 |
Analysts |
2 |
|
|
0.0
|
MPLT
|
MapLight Therapeutics, Inc.
|
13.31
|
strong_buy
|
N/A
/
0%
|
11%
|
40.3
↑
|
0.95
|
N/A
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
584,360,704 |
Cash |
304,724,992 |
| Debt |
1,987,000 |
Recommendation |
strong_buy |
| RSI |
40.3 |
MACD |
-2.67 |
| Signal |
-3.62 |
Histogram |
0.95 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-112.0% |
| Target Price |
26.69 |
Analysts |
13 |
|
|
-18.0
|
MPT
|
Medical Properties Trust, Inc.
|
4.03
|
hold
|
2%
/
-3%
|
3%
|
37.1
↑
|
-0.00
|
-0.18
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Healthcare Facilities |
| Market Cap |
2,442,547,968 |
Cash |
396,558,016 |
| Debt |
9,704,995,840 |
Recommendation |
hold |
| RSI |
37.1 |
MACD |
-0.15 |
| Signal |
-0.15 |
Histogram |
-0.00 |
| Revenue Growth |
2.0% |
EPS Growth |
N/A |
| Gross Margin |
96.0% |
ROE |
-1.0% |
| Target Price |
5.11 |
Analysts |
7 |
|
|
25.0
|
MUSA
|
Murphy USA Inc.
|
536.45
|
buy
|
41%
/
3%
|
68%
|
42.7
↑
|
-4.23
|
0.25
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Specialty Retail |
| Market Cap |
9,248,806,912 |
Cash |
175,400,000 |
| Debt |
2,762,400,000 |
Recommendation |
buy |
| RSI |
42.7 |
MACD |
-13.75 |
| Signal |
-9.52 |
Histogram |
-4.23 |
| Revenue Growth |
41.0% |
EPS Growth |
53.0% |
| Gross Margin |
8.0% |
ROE |
86.0% |
| Target Price |
622.70 |
Analysts |
10 |
|
|
10.0
|
NATL
|
NCR Atleos Corporation
|
46.28
|
none
|
0%
/
4%
|
87%
|
48.7
↑
|
-0.10
|
0.10
|
▼ |
| Sector |
Technology |
Industry |
Software - Application |
| Market Cap |
3,418,472,192 |
Cash |
429,000,000 |
| Debt |
2,943,000,064 |
Recommendation |
none |
| RSI |
48.7 |
MACD |
-0.04 |
| Signal |
0.07 |
Histogram |
-0.10 |
| Revenue Growth |
0.0% |
EPS Growth |
65.0% |
| Gross Margin |
25.0% |
ROE |
49.0% |
| Target Price |
50.27 |
Analysts |
3 |
|
|
6.0
|
NBIX
|
Neurocrine Biosciences, Inc.
|
156.76
|
strong_buy
|
40%
/
21%
|
54%
|
45.4
↑
|
0.43
|
0.06
|
▼ |
| Sector |
Healthcare |
Industry |
Drug Manufacturers - Specialty & Generic |
| Market Cap |
15,660,072,960 |
Cash |
389,800,000 |
| Debt |
461,600,000 |
Recommendation |
strong_buy |
| RSI |
45.4 |
MACD |
-3.48 |
| Signal |
-3.90 |
Histogram |
0.43 |
| Revenue Growth |
40.0% |
EPS Growth |
31.0% |
| Gross Margin |
64.0% |
ROE |
22.0% |
| Target Price |
211.57 |
Analysts |
27 |
|
|
-34.0
|
NCMI
|
National CineMedia, Inc.
|
2.53
|
none
|
13%
/
-3%
|
12%
|
35.0
↑
|
-0.02
|
-0.34
|
▼ |
| Sector |
Communication Services |
Industry |
Advertising Agencies |
| Market Cap |
244,583,136 |
Cash |
43,100,000 |
| Debt |
21,900,000 |
Recommendation |
none |
| RSI |
35.0 |
MACD |
-0.32 |
| Signal |
-0.30 |
Histogram |
-0.02 |
| Revenue Growth |
13.0% |
EPS Growth |
N/A |
| Gross Margin |
44.0% |
ROE |
-2.0% |
| Target Price |
4.81 |
Analysts |
4 |
|
|
4.0
|
NGS
|
Natural Gas Services Group, Inc
|
35.27
|
none
|
24%
/
11%
|
53%
|
41.6
↑
|
0.01
|
0.04
|
▼ |
| Sector |
Energy |
Industry |
Oil & Gas Equipment & Services |
| Market Cap |
447,441,504 |
Cash |
84,000 |
| Debt |
329,281,984 |
Recommendation |
none |
| RSI |
41.6 |
MACD |
-0.82 |
| Signal |
-0.82 |
Histogram |
0.01 |
| Revenue Growth |
24.0% |
EPS Growth |
-27.0% |
| Gross Margin |
59.0% |
ROE |
7.0% |
| Target Price |
56.00 |
Analysts |
3 |
|
|
-6.0
|
NGVC
|
Natural Grocers by Vitamin Cott
|
27.55
|
strong_buy
|
2%
/
4%
|
25%
|
41.2
↑
|
0.04
|
-0.06
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Grocery Stores |
| Market Cap |
633,300,032 |
Cash |
17,467,000 |
| Debt |
322,680,000 |
Recommendation |
strong_buy |
| RSI |
41.2 |
MACD |
-0.86 |
| Signal |
-0.90 |
Histogram |
0.04 |
| Revenue Growth |
2.0% |
EPS Growth |
-4.0% |
| Gross Margin |
33.0% |
ROE |
22.0% |
| Target Price |
44.67 |
Analysts |
3 |
|
|
47.0
|
NHC
|
National HealthCare Corporation
|
218.97
|
none
|
9%
/
9%
|
86%
|
46.1
↑
|
-1.66
|
0.47
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
3,487,792,640 |
Cash |
210,190,000 |
| Debt |
31,409,000 |
Recommendation |
none |
| RSI |
46.1 |
MACD |
1.10 |
| Signal |
2.75 |
Histogram |
-1.66 |
| Revenue Growth |
9.0% |
EPS Growth |
67.0% |
| Gross Margin |
39.0% |
ROE |
13.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
-4.0
|
NHI
|
National Health Investors, Inc.
|
72.27
|
buy
|
-3%
/
38%
|
22%
|
42.5
↑
|
-0.06
|
-0.04
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Healthcare Facilities |
| Market Cap |
3,537,424,384 |
Cash |
113,375,000 |
| Debt |
1,524,724,992 |
Recommendation |
buy |
| RSI |
42.5 |
MACD |
-0.92 |
| Signal |
-0.86 |
Histogram |
-0.06 |
| Revenue Growth |
-3.0% |
EPS Growth |
-43.0% |
| Gross Margin |
74.0% |
ROE |
11.0% |
| Target Price |
82.12 |
Analysts |
8 |
|
|
-7.0
|
NI
|
NiSource Inc
|
40.96
|
buy
|
5%
/
13%
|
25%
|
32.6
↑
|
0.04
|
-0.07
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Gas |
| Market Cap |
19,455,752,192 |
Cash |
70,000,000 |
| Debt |
17,443,000,320 |
Recommendation |
buy |
| RSI |
32.6 |
MACD |
-1.06 |
| Signal |
-1.10 |
Histogram |
0.04 |
| Revenue Growth |
5.0% |
EPS Growth |
-58.0% |
| Gross Margin |
51.0% |
ROE |
9.0% |
| Target Price |
49.93 |
Analysts |
14 |
|
|
8.0
|
NJR
|
NewJersey Resources Corporation
|
54.10
|
none
|
17%
/
16%
|
65%
|
42.4
↑
|
-0.06
|
0.08
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Gas |
| Market Cap |
5,438,681,600 |
Cash |
33,955,000 |
| Debt |
3,880,007,936 |
Recommendation |
none |
| RSI |
42.4 |
MACD |
-0.88 |
| Signal |
-0.82 |
Histogram |
-0.06 |
| Revenue Growth |
17.0% |
EPS Growth |
N/A |
| Gross Margin |
39.0% |
ROE |
14.0% |
| Target Price |
60.00 |
Analysts |
7 |
|
|
8.0
|
NNN
|
NNN REIT, Inc.
|
45.24
|
hold
|
8%
/
40%
|
68%
|
38.3
↑
|
-0.10
|
0.08
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
8,688,633,856 |
Cash |
4,223,000 |
| Debt |
5,001,272,832 |
Recommendation |
hold |
| RSI |
38.3 |
MACD |
-0.40 |
| Signal |
-0.30 |
Histogram |
-0.10 |
| Revenue Growth |
8.0% |
EPS Growth |
-4.0% |
| Gross Margin |
96.0% |
ROE |
9.0% |
| Target Price |
47.80 |
Analysts |
15 |
|
|
11.0
|
NODK
|
NI Holdings, Inc.
|
15.01
|
none
|
-8%
/
3%
|
66%
|
40.1
↑
|
-0.02
|
0.11
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Property & Casualty |
| Market Cap |
310,355,840 |
Cash |
51,609,000 |
| Debt |
1,158,000 |
Recommendation |
none |
| RSI |
40.1 |
MACD |
-0.11 |
| Signal |
-0.09 |
Histogram |
-0.02 |
| Revenue Growth |
-8.0% |
EPS Growth |
N/A |
| Gross Margin |
4.0% |
ROE |
3.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
19.0
|
NTB
|
Bank of N.T. Butterfield & Son
|
58.91
|
none
|
8%
/
37%
|
79%
|
40.3
↑
|
-0.35
|
0.19
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Diversified |
| Market Cap |
2,332,072,448 |
Cash |
3,160,995,072 |
| Debt |
40,325,000 |
Recommendation |
none |
| RSI |
40.3 |
MACD |
-0.53 |
| Signal |
-0.18 |
Histogram |
-0.35 |
| Revenue Growth |
8.0% |
EPS Growth |
-7.0% |
| Gross Margin |
0.0% |
ROE |
21.0% |
| Target Price |
64.00 |
Analysts |
3 |
|
|
9.0
|
NTST
|
NetSTREIT Corp.
|
20.44
|
strong_buy
|
27%
/
6%
|
67%
|
44.2
↑
|
0.00
|
0.09
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
2,086,510,592 |
Cash |
34,637,000 |
| Debt |
1,403,266,944 |
Recommendation |
strong_buy |
| RSI |
44.2 |
MACD |
-0.18 |
| Signal |
-0.18 |
Histogram |
0.00 |
| Revenue Growth |
27.0% |
EPS Growth |
53.0% |
| Gross Margin |
90.0% |
ROE |
1.0% |
| Target Price |
23.18 |
Analysts |
19 |
|
|
35.0
|
NUE
|
Nucor Corporation
|
251.92
|
buy
|
23%
/
8%
|
84%
|
48.0
↑
|
-2.05
|
0.35
|
▼ |
| Sector |
Basic Materials |
Industry |
Steel |
| Market Cap |
56,832,356,352 |
Cash |
2,692,000,000 |
| Debt |
7,098,999,808 |
Recommendation |
buy |
| RSI |
48.0 |
MACD |
-0.83 |
| Signal |
1.22 |
Histogram |
-2.05 |
| Revenue Growth |
23.0% |
EPS Growth |
94.0% |
| Gross Margin |
16.0% |
ROE |
15.0% |
| Target Price |
282.81 |
Analysts |
16 |
|
|
9.0
|
NWE
|
NorthWestern Energy Group, Inc.
|
69.91
|
buy
|
15%
/
10%
|
85%
|
47.7
↑
|
-0.04
|
0.09
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
4,325,935,104 |
Cash |
4,180,000 |
| Debt |
3,596,605,952 |
Recommendation |
buy |
| RSI |
47.7 |
MACD |
-0.06 |
| Signal |
-0.01 |
Histogram |
-0.04 |
| Revenue Growth |
15.0% |
EPS Growth |
16.0% |
| Gross Margin |
56.0% |
ROE |
6.0% |
| Target Price |
74.25 |
Analysts |
6 |
|
|
6.0
|
NWN
|
Northwest Natural Holding Compa
|
49.41
|
buy
|
3%
/
10%
|
65%
|
45.6
↑
|
-0.14
|
0.06
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Gas |
| Market Cap |
2,083,630,080 |
Cash |
26,834,000 |
| Debt |
2,701,864,960 |
Recommendation |
buy |
| RSI |
45.6 |
MACD |
-0.12 |
| Signal |
0.03 |
Histogram |
-0.14 |
| Revenue Growth |
3.0% |
EPS Growth |
N/A |
| Gross Margin |
45.0% |
ROE |
8.0% |
| Target Price |
57.40 |
Analysts |
5 |
|
|
-18.0
|
NXT
|
Nextpower Inc.
|
83.07
|
strong_buy
|
8%
/
16%
|
20%
|
35.6
↑
|
-0.73
|
-0.18
|
▼ |
| Sector |
Technology |
Industry |
Solar |
| Market Cap |
13,126,860,800 |
Cash |
1,213,897,984 |
| Debt |
38,400,000 |
Recommendation |
strong_buy |
| RSI |
35.6 |
MACD |
-5.39 |
| Signal |
-4.66 |
Histogram |
-0.73 |
| Revenue Growth |
8.0% |
EPS Growth |
3.0% |
| Gross Margin |
23.0% |
ROE |
27.0% |
| Target Price |
141.52 |
Analysts |
27 |
|
|
-3.0
|
NYT
|
New York Times Company (The)
|
67.73
|
buy
|
11%
/
13%
|
43%
|
47.8
↑
|
0.53
|
-0.03
|
▼ |
| Sector |
Communication Services |
Industry |
Publishing |
| Market Cap |
10,993,089,536 |
Cash |
660,812,032 |
| Debt |
0 |
Recommendation |
buy |
| RSI |
47.8 |
MACD |
-0.94 |
| Signal |
-1.47 |
Histogram |
0.53 |
| Revenue Growth |
11.0% |
EPS Growth |
14.0% |
| Gross Margin |
51.0% |
ROE |
20.0% |
| Target Price |
77.67 |
Analysts |
9 |
|
|
5.0
|
O
|
Realty Income Corporation
|
61.36
|
buy
|
10%
/
21%
|
61%
|
38.2
↑
|
-0.15
|
0.05
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
58,646,593,536 |
Cash |
569,948,032 |
| Debt |
31,333,789,696 |
Recommendation |
buy |
| RSI |
38.2 |
MACD |
-0.39 |
| Signal |
-0.24 |
Histogram |
-0.15 |
| Revenue Growth |
10.0% |
EPS Growth |
69.0% |
| Gross Margin |
93.0% |
ROE |
3.0% |
| Target Price |
68.21 |
Analysts |
20 |
|
|
37.0
|
ODC
|
Oil-Dri Corporation Of America
|
90.77
|
none
|
9%
/
11%
|
74%
|
45.0
↑
|
0.07
|
0.37
|
▼ |
| Sector |
Basic Materials |
Industry |
Specialty Chemicals |
| Market Cap |
N/A |
Cash |
62,941,000 |
| Debt |
54,329,000 |
Recommendation |
none |
| RSI |
45.0 |
MACD |
-1.30 |
| Signal |
-1.38 |
Histogram |
0.07 |
| Revenue Growth |
9.0% |
EPS Growth |
25.0% |
| Gross Margin |
28.0% |
ROE |
21.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
-21.0
|
OFIX
|
Orthofix Medical Inc.
|
9.43
|
none
|
4%
/
-7%
|
7%
|
35.9
↑
|
-0.08
|
-0.21
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Devices |
| Market Cap |
392,090,016 |
Cash |
103,810,000 |
| Debt |
261,900,000 |
Recommendation |
none |
| RSI |
35.9 |
MACD |
-0.40 |
| Signal |
-0.31 |
Histogram |
-0.08 |
| Revenue Growth |
4.0% |
EPS Growth |
N/A |
| Gross Margin |
71.0% |
ROE |
-14.0% |
| Target Price |
13.00 |
Analysts |
4 |
|
|
2.0
|
OGE
|
OGE Energy Corp
|
45.99
|
hold
|
-4%
/
14%
|
54%
|
41.5
↑
|
-0.05
|
0.02
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
9,449,027,584 |
Cash |
900,000 |
| Debt |
5,843,200,000 |
Recommendation |
hold |
| RSI |
41.5 |
MACD |
-0.52 |
| Signal |
-0.47 |
Histogram |
-0.05 |
| Revenue Growth |
-4.0% |
EPS Growth |
6.0% |
| Gross Margin |
45.0% |
ROE |
10.0% |
| Target Price |
50.45 |
Analysts |
11 |
|
|
6.0
|
OHI
|
Omega Healthcare Investors, Inc
|
46.79
|
buy
|
11%
/
68%
|
69%
|
46.4
↑
|
-0.03
|
0.06
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Healthcare Facilities |
| Market Cap |
14,684,482,560 |
Cash |
39,036,000 |
| Debt |
4,032,576,000 |
Recommendation |
buy |
| RSI |
46.4 |
MACD |
-0.49 |
| Signal |
-0.46 |
Histogram |
-0.03 |
| Revenue Growth |
11.0% |
EPS Growth |
161.0% |
| Gross Margin |
98.0% |
ROE |
17.0% |
| Target Price |
51.94 |
Analysts |
18 |
|
|
-17.0
|
OLMA
|
Olema Pharmaceuticals, Inc.
|
10.56
|
strong_buy
|
N/A
/
0%
|
14%
|
43.6
↑
|
-0.01
|
-0.17
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
898,600,448 |
Cash |
461,070,016 |
| Debt |
3,660,000 |
Recommendation |
strong_buy |
| RSI |
43.6 |
MACD |
-0.24 |
| Signal |
-0.23 |
Histogram |
-0.01 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-53.0% |
| Target Price |
39.30 |
Analysts |
10 |
|
|
-6.0
|
ORA
|
Ormat Technologies, Inc.
|
107.29
|
buy
|
11%
/
11%
|
32%
|
49.8
↑
|
-0.34
|
-0.06
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Renewable |
| Market Cap |
6,336,644,608 |
Cash |
513,747,008 |
| Debt |
3,411,760,896 |
Recommendation |
buy |
| RSI |
49.8 |
MACD |
-0.82 |
| Signal |
-0.48 |
Histogram |
-0.34 |
| Revenue Growth |
11.0% |
EPS Growth |
-6.0% |
| Gross Margin |
28.0% |
ROE |
5.0% |
| Target Price |
132.83 |
Analysts |
12 |
|
|
-29.0
|
OSG
|
Octave Specialty Group, Inc.
|
4.54
|
strong_buy
|
51%
/
-51%
|
10%
|
38.2
↑
|
0.02
|
-0.29
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Specialty |
| Market Cap |
209,038,896 |
Cash |
109,301,000 |
| Debt |
155,459,008 |
Recommendation |
strong_buy |
| RSI |
38.2 |
MACD |
-0.29 |
| Signal |
-0.31 |
Histogram |
0.02 |
| Revenue Growth |
51.0% |
EPS Growth |
N/A |
| Gross Margin |
62.0% |
ROE |
-7.0% |
| Target Price |
13.50 |
Analysts |
2 |
|
|
-13.0
|
OSIS
|
OSI Systems, Inc.
|
208.52
|
strong_buy
|
-4%
/
9%
|
10%
|
39.3
↑
|
-1.93
|
-0.13
|
▼ |
| Sector |
Technology |
Industry |
Electronic Components |
| Market Cap |
3,294,248,192 |
Cash |
359,832,000 |
| Debt |
1,049,841,984 |
Recommendation |
strong_buy |
| RSI |
39.3 |
MACD |
-4.04 |
| Signal |
-2.11 |
Histogram |
-1.93 |
| Revenue Growth |
-4.0% |
EPS Growth |
8.0% |
| Gross Margin |
33.0% |
ROE |
17.0% |
| Target Price |
281.14 |
Analysts |
7 |
|
|
19.0
|
OUT
|
OUTFRONT Media Inc.
|
29.81
|
none
|
14%
/
13%
|
77%
|
40.6
↑
|
0.02
|
0.19
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Specialty |
| Market Cap |
5,213,603,328 |
Cash |
31,200,000 |
| Debt |
4,132,499,968 |
Recommendation |
none |
| RSI |
40.6 |
MACD |
-0.50 |
| Signal |
-0.51 |
Histogram |
0.02 |
| Revenue Growth |
14.0% |
EPS Growth |
340.0% |
| Gross Margin |
51.0% |
ROE |
35.0% |
| Target Price |
38.00 |
Analysts |
6 |
|
|
19.0
|
P
|
Everpure, Inc.
|
93.78
|
buy
|
N/A
/
6%
|
60%
|
46.8
↑
|
-2.79
|
0.19
|
▼ |
| Sector |
Technology |
Industry |
Computer Hardware |
| Market Cap |
31,046,621,184 |
Cash |
1,234,183,936 |
| Debt |
911,254,016 |
Recommendation |
buy |
| RSI |
46.8 |
MACD |
4.09 |
| Signal |
6.88 |
Histogram |
-2.79 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
70.0% |
ROE |
17.0% |
| Target Price |
111.05 |
Analysts |
19 |
|
|
11.0
|
PAMT
|
PAMT CORP
|
12.62
|
none
|
9%
/
-7%
|
51%
|
45.8
↑
|
-0.01
|
0.11
|
▼ |
| Sector |
Industrials |
Industry |
Trucking |
| Market Cap |
251,725,920 |
Cash |
56,942,000 |
| Debt |
339,620,992 |
Recommendation |
none |
| RSI |
45.8 |
MACD |
-0.72 |
| Signal |
-0.71 |
Histogram |
-0.01 |
| Revenue Growth |
9.0% |
EPS Growth |
N/A |
| Gross Margin |
12.0% |
ROE |
-19.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
5.0
|
PCYO
|
Pure Cycle Corporation
|
11.11
|
none
|
60%
/
44%
|
60%
|
48.3
↑
|
-0.04
|
0.05
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Water |
| Market Cap |
275,432,960 |
Cash |
8,440,000 |
| Debt |
14,127,000 |
Recommendation |
none |
| RSI |
48.3 |
MACD |
0.14 |
| Signal |
0.17 |
Histogram |
-0.04 |
| Revenue Growth |
60.0% |
EPS Growth |
33.0% |
| Gross Margin |
62.0% |
ROE |
10.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
5.0
|
PECO
|
Phillips Edison & Company, Inc.
|
38.92
|
buy
|
7%
/
19%
|
57%
|
34.9
↑
|
-0.07
|
0.05
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
5,526,316,544 |
Cash |
7,132,000 |
| Debt |
2,450,755,072 |
Recommendation |
buy |
| RSI |
34.9 |
MACD |
-0.68 |
| Signal |
-0.61 |
Histogram |
-0.07 |
| Revenue Growth |
7.0% |
EPS Growth |
219.0% |
| Gross Margin |
71.0% |
ROE |
6.0% |
| Target Price |
45.92 |
Analysts |
13 |
|
|
-7.0
|
PEG
|
Public Service Enterprise Group
|
73.48
|
buy
|
-9%
/
16%
|
7%
|
36.6
↑
|
-0.02
|
-0.07
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
36,479,365,120 |
Cash |
192,000,000 |
| Debt |
24,678,000,640 |
Recommendation |
buy |
| RSI |
36.6 |
MACD |
-1.23 |
| Signal |
-1.21 |
Histogram |
-0.02 |
| Revenue Growth |
-9.0% |
EPS Growth |
-43.0% |
| Gross Margin |
33.0% |
ROE |
12.0% |
| Target Price |
85.47 |
Analysts |
18 |
|
|
1.0
|
PFGC
|
Performance Food Group Company
|
99.20
|
buy
|
7%
/
1%
|
51%
|
30.7
↑
|
-0.86
|
0.01
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Food Distribution |
| Market Cap |
15,840,757,760 |
Cash |
93,200,000 |
| Debt |
7,782,499,840 |
Recommendation |
buy |
| RSI |
30.7 |
MACD |
-2.70 |
| Signal |
-1.84 |
Histogram |
-0.86 |
| Revenue Growth |
7.0% |
EPS Growth |
23.0% |
| Gross Margin |
13.0% |
ROE |
8.0% |
| Target Price |
123.62 |
Analysts |
13 |
|
|
29.0
|
PFIS
|
Peoples Financial Services Corp
|
68.69
|
none
|
1%
/
30%
|
89%
|
43.5
↑
|
-0.42
|
0.29
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
697,021,824 |
Cash |
270,583,008 |
| Debt |
345,463,008 |
Recommendation |
none |
| RSI |
43.5 |
MACD |
0.10 |
| Signal |
0.52 |
Histogram |
-0.42 |
| Revenue Growth |
1.0% |
EPS Growth |
-12.0% |
| Gross Margin |
0.0% |
ROE |
11.0% |
| Target Price |
73.50 |
Analysts |
2 |
|
|
9.0
|
PGNY
|
Progyny, Inc.
|
25.66
|
strong_buy
|
5%
/
6%
|
58%
|
37.2
↑
|
0.00
|
0.09
|
▼ |
| Sector |
Healthcare |
Industry |
Healthcare Plans |
| Market Cap |
1,994,896,768 |
Cash |
236,924,992 |
| Debt |
22,495,000 |
Recommendation |
strong_buy |
| RSI |
37.2 |
MACD |
-1.04 |
| Signal |
-1.04 |
Histogram |
0.00 |
| Revenue Growth |
5.0% |
EPS Growth |
79.0% |
| Gross Margin |
25.0% |
ROE |
16.0% |
| Target Price |
34.25 |
Analysts |
12 |
|
|
13.0
|
PINE
|
Alpine Income Property Trust, I
|
19.54
|
buy
|
35%
/
9%
|
76%
|
42.8
↑
|
-0.00
|
0.13
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
368,034,400 |
Cash |
6,911,000 |
| Debt |
389,624,000 |
Recommendation |
buy |
| RSI |
42.8 |
MACD |
-0.16 |
| Signal |
-0.16 |
Histogram |
-0.00 |
| Revenue Growth |
35.0% |
EPS Growth |
N/A |
| Gross Margin |
86.0% |
ROE |
2.0% |
| Target Price |
21.73 |
Analysts |
11 |
|
|
27.0
|
PNTG
|
The Pennant Group, Inc.
|
37.74
|
strong_buy
|
36%
/
3%
|
77%
|
42.7
↑
|
-0.24
|
0.27
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
1,295,170,048 |
Cash |
15,273,000 |
| Debt |
495,552,992 |
Recommendation |
strong_buy |
| RSI |
42.7 |
MACD |
-0.38 |
| Signal |
-0.15 |
Histogram |
-0.24 |
| Revenue Growth |
36.0% |
EPS Growth |
25.0% |
| Gross Margin |
20.0% |
ROE |
10.0% |
| Target Price |
46.67 |
Analysts |
6 |
|
|
5.0
|
PNW
|
Pinnacle West Capital Corporati
|
97.66
|
hold
|
7%
/
12%
|
58%
|
36.2
↑
|
-0.07
|
0.05
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
11,833,697,280 |
Cash |
9,124,000 |
| Debt |
16,505,294,848 |
Recommendation |
hold |
| RSI |
36.2 |
MACD |
-1.40 |
| Signal |
-1.33 |
Histogram |
-0.07 |
| Revenue Growth |
7.0% |
EPS Growth |
-10.0% |
| Gross Margin |
43.0% |
ROE |
9.0% |
| Target Price |
105.85 |
Analysts |
13 |
|
|
3.0
|
POR
|
Portland General Electric Co
|
49.06
|
hold
|
1%
/
7%
|
66%
|
41.8
↑
|
-0.02
|
0.03
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
5,833,344,000 |
Cash |
35,000,000 |
| Debt |
5,614,000,128 |
Recommendation |
hold |
| RSI |
41.8 |
MACD |
-0.34 |
| Signal |
-0.31 |
Histogram |
-0.02 |
| Revenue Growth |
1.0% |
EPS Growth |
5.0% |
| Gross Margin |
48.0% |
ROE |
6.0% |
| Target Price |
53.68 |
Analysts |
11 |
|
|
-15.0
|
POST
|
Post Holdings, Inc.
|
83.59
|
none
|
-2%
/
3%
|
19%
|
49.9
↑
|
0.61
|
-0.15
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Packaged Foods |
| Market Cap |
3,868,282,368 |
Cash |
266,500,000 |
| Debt |
7,632,600,064 |
Recommendation |
none |
| RSI |
49.9 |
MACD |
-1.44 |
| Signal |
-2.06 |
Histogram |
0.61 |
| Revenue Growth |
-2.0% |
EPS Growth |
-28.0% |
| Gross Margin |
29.0% |
ROE |
8.0% |
| Target Price |
105.17 |
Analysts |
6 |
|
|
16.0
|
POWW
|
Outdoor Holding Company
|
2.18
|
none
|
22%
/
12%
|
67%
|
46.5
↑
|
-0.01
|
0.16
|
▼ |
| Sector |
Industrials |
Industry |
Aerospace & Defense |
| Market Cap |
252,913,488 |
Cash |
68,777,368 |
| Debt |
10,876,666 |
Recommendation |
none |
| RSI |
46.5 |
MACD |
-0.01 |
| Signal |
-0.00 |
Histogram |
-0.01 |
| Revenue Growth |
22.0% |
EPS Growth |
N/A |
| Gross Margin |
88.0% |
ROE |
2.0% |
| Target Price |
3.50 |
Analysts |
2 |
|
|
-3.0
|
PPL
|
PPL Corporation
|
34.47
|
buy
|
4%
/
13%
|
26%
|
41.5
↑
|
-0.09
|
-0.03
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
25,737,033,728 |
Cash |
332,000,000 |
| Debt |
20,376,000,512 |
Recommendation |
buy |
| RSI |
41.5 |
MACD |
-0.32 |
| Signal |
-0.22 |
Histogram |
-0.09 |
| Revenue Growth |
4.0% |
EPS Growth |
21.0% |
| Gross Margin |
44.0% |
ROE |
9.0% |
| Target Price |
40.93 |
Analysts |
14 |
|
|
11.0
|
PRI
|
Primerica, Inc.
|
290.35
|
buy
|
9%
/
23%
|
57%
|
36.8
↑
|
-2.56
|
0.11
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Life |
| Market Cap |
8,937,435,136 |
Cash |
637,508,992 |
| Debt |
1,804,438,016 |
Recommendation |
buy |
| RSI |
36.8 |
MACD |
-4.27 |
| Signal |
-1.71 |
Histogram |
-2.56 |
| Revenue Growth |
9.0% |
EPS Growth |
20.0% |
| Gross Margin |
72.0% |
ROE |
33.0% |
| Target Price |
332.83 |
Analysts |
6 |
|
|
-43.0
|
PRIM
|
Primoris Services Corporation
|
72.25
|
none
|
-11%
/
2%
|
0%
|
35.7
↑
|
-0.33
|
-0.43
|
▼ |
| Sector |
Industrials |
Industry |
Engineering & Construction |
| Market Cap |
3,967,121,152 |
Cash |
218,200,000 |
| Debt |
1,279,100,032 |
Recommendation |
none |
| RSI |
35.7 |
MACD |
-3.68 |
| Signal |
-3.36 |
Histogram |
-0.33 |
| Revenue Growth |
-11.0% |
EPS Growth |
N/A |
| Gross Margin |
9.0% |
ROE |
9.0% |
| Target Price |
119.79 |
Analysts |
14 |
|
|
7.0
|
PRMB
|
Primo Brands Corporation
|
22.92
|
none
|
4%
/
1%
|
79%
|
45.9
↑
|
-0.08
|
0.07
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Beverages - Non-Alcoholic |
| Market Cap |
8,324,705,280 |
Cash |
368,900,000 |
| Debt |
5,697,099,776 |
Recommendation |
none |
| RSI |
45.9 |
MACD |
-0.22 |
| Signal |
-0.13 |
Histogram |
-0.08 |
| Revenue Growth |
4.0% |
EPS Growth |
163.0% |
| Gross Margin |
31.0% |
ROE |
4.0% |
| Target Price |
30.36 |
Analysts |
11 |
|
|
22.0
|
PSMT
|
PriceSmart, Inc.
|
172.05
|
none
|
12%
/
3%
|
72%
|
41.9
↑
|
-0.29
|
0.22
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Discount Stores |
| Market Cap |
5,225,921,024 |
Cash |
322,593,984 |
| Debt |
334,414,016 |
Recommendation |
none |
| RSI |
41.9 |
MACD |
-3.25 |
| Signal |
-2.96 |
Histogram |
-0.29 |
| Revenue Growth |
12.0% |
EPS Growth |
12.0% |
| Gross Margin |
18.0% |
ROE |
12.0% |
| Target Price |
153.33 |
Analysts |
3 |
|
|
1.0
|
PTCT
|
PTC Therapeutics, Inc.
|
70.56
|
buy
|
101%
/
-4%
|
49%
|
43.3
↑
|
0.09
|
0.01
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
5,849,766,912 |
Cash |
2,229,082,112 |
| Debt |
3,017,902,080 |
Recommendation |
buy |
| RSI |
43.3 |
MACD |
-1.22 |
| Signal |
-1.30 |
Histogram |
0.09 |
| Revenue Growth |
101.0% |
EPS Growth |
N/A |
| Gross Margin |
50.0% |
ROE |
N/A |
| Target Price |
99.29 |
Analysts |
14 |
|
|
16.0
|
PWR
|
Quanta Services, Inc.
|
611.39
|
strong_buy
|
41%
/
4%
|
58%
|
40.7
↑
|
-7.07
|
0.16
|
▼ |
| Sector |
Industrials |
Industry |
Engineering & Construction |
| Market Cap |
90,611,965,952 |
Cash |
506,431,008 |
| Debt |
6,603,134,976 |
Recommendation |
strong_buy |
| RSI |
40.7 |
MACD |
-13.57 |
| Signal |
-6.50 |
Histogram |
-7.07 |
| Revenue Growth |
41.0% |
EPS Growth |
95.0% |
| Gross Margin |
15.0% |
ROE |
15.0% |
| Target Price |
770.04 |
Analysts |
28 |
|
|
-1.0
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
25.81
|
strong_buy
|
28%
/
-82%
|
41%
|
45.5
↑
|
0.08
|
-0.01
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
2,524,861,184 |
Cash |
292,000,000 |
| Debt |
1,202,000,000 |
Recommendation |
strong_buy |
| RSI |
45.5 |
MACD |
-0.45 |
| Signal |
-0.53 |
Histogram |
0.08 |
| Revenue Growth |
28.0% |
EPS Growth |
N/A |
| Gross Margin |
-21.0% |
ROE |
N/A |
| Target Price |
55.05 |
Analysts |
19 |
|
|
29.0
|
RBCAA
|
Republic Bancorp, Inc.
|
94.71
|
none
|
4%
/
33%
|
84%
|
49.0
↑
|
-0.59
|
0.29
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
1,863,281,024 |
Cash |
358,668,992 |
| Debt |
260,887,008 |
Recommendation |
none |
| RSI |
49.0 |
MACD |
-0.06 |
| Signal |
0.53 |
Histogram |
-0.59 |
| Revenue Growth |
4.0% |
EPS Growth |
4.0% |
| Gross Margin |
0.0% |
ROE |
12.0% |
| Target Price |
98.00 |
Analysts |
1 |
|
|
4.0
|
REG
|
Regency Centers Corporation
|
76.06
|
buy
|
9%
/
33%
|
62%
|
41.8
↑
|
-0.01
|
0.04
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
14,119,122,944 |
Cash |
193,275,008 |
| Debt |
5,143,966,208 |
Recommendation |
buy |
| RSI |
41.8 |
MACD |
-0.97 |
| Signal |
-0.96 |
Histogram |
-0.01 |
| Revenue Growth |
9.0% |
EPS Growth |
9.0% |
| Gross Margin |
72.0% |
ROE |
8.0% |
| Target Price |
87.06 |
Analysts |
18 |
|
|
10.0
|
REX
|
REX American Resources Corporat
|
41.99
|
none
|
4%
/
14%
|
56%
|
42.8
↑
|
-0.21
|
0.10
|
▼ |
| Sector |
Basic Materials |
Industry |
Chemicals |
| Market Cap |
1,361,974,528 |
Cash |
364,308,000 |
| Debt |
19,541,000 |
Recommendation |
none |
| RSI |
42.8 |
MACD |
-0.76 |
| Signal |
-0.56 |
Histogram |
-0.21 |
| Revenue Growth |
4.0% |
EPS Growth |
118.0% |
| Gross Margin |
17.0% |
ROE |
16.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
-2.0
|
RGCO
|
RGC Resources Inc.
|
21.57
|
none
|
-1%
/
13%
|
23%
|
43.5
↑
|
0.05
|
-0.02
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Gas |
| Market Cap |
225,687,584 |
Cash |
3,023,763 |
| Debt |
148,902,688 |
Recommendation |
none |
| RSI |
43.5 |
MACD |
-0.25 |
| Signal |
-0.30 |
Histogram |
0.05 |
| Revenue Growth |
-1.0% |
EPS Growth |
0.0% |
| Gross Margin |
32.0% |
ROE |
12.0% |
| Target Price |
23.00 |
Analysts |
1 |
|
|
126.0
|
RLAY
|
Relay Therapeutics, Inc.
|
18.49
|
strong_buy
|
-48%
/
0%
|
87%
|
42.0
↑
|
-0.25
|
1.26
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
4,113,288,448 |
Cash |
910,934,016 |
| Debt |
30,658,000 |
Recommendation |
strong_buy |
| RSI |
42.0 |
MACD |
0.03 |
| Signal |
0.28 |
Histogram |
-0.25 |
| Revenue Growth |
-48.0% |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-37.0% |
| Target Price |
27.08 |
Analysts |
13 |
|
|
-32.0
|
ROL
|
Rollins, Inc.
|
36.19
|
hold
|
8%
/
14%
|
1%
|
36.3
↑
|
0.23
|
-0.32
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Personal Services |
| Market Cap |
17,504,069,632 |
Cash |
109,085,000 |
| Debt |
1,115,303,040 |
Recommendation |
hold |
| RSI |
36.3 |
MACD |
-1.12 |
| Signal |
-1.35 |
Histogram |
0.23 |
| Revenue Growth |
8.0% |
EPS Growth |
3.0% |
| Gross Margin |
52.0% |
ROE |
37.0% |
| Target Price |
45.59 |
Analysts |
17 |
|
|
20.0
|
ROST
|
Ross Stores, Inc.
|
229.24
|
buy
|
13%
/
11%
|
77%
|
39.5
↑
|
-2.16
|
0.20
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Apparel Retail |
| Market Cap |
73,314,516,992 |
Cash |
4,288,123,904 |
| Debt |
4,739,150,848 |
Recommendation |
buy |
| RSI |
39.5 |
MACD |
-2.20 |
| Signal |
-0.04 |
Histogram |
-2.16 |
| Revenue Growth |
13.0% |
EPS Growth |
70.0% |
| Gross Margin |
34.0% |
ROE |
43.0% |
| Target Price |
269.94 |
Analysts |
18 |
|
|
27.0
|
RRBI
|
Red River Bancshares, Inc.
|
100.15
|
none
|
10%
/
36%
|
92%
|
49.2
↑
|
-0.41
|
0.27
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
663,480,320 |
Cash |
195,396,000 |
| Debt |
1,383,000 |
Recommendation |
none |
| RSI |
49.2 |
MACD |
0.54 |
| Signal |
0.95 |
Histogram |
-0.41 |
| Revenue Growth |
10.0% |
EPS Growth |
18.0% |
| Gross Margin |
0.0% |
ROE |
13.0% |
| Target Price |
108.00 |
Analysts |
2 |
|
|
21.0
|
RS
|
Reliance, Inc.
|
390.11
|
hold
|
26%
/
6%
|
77%
|
44.3
↑
|
-3.47
|
0.21
|
▼ |
| Sector |
Basic Materials |
Industry |
Steel |
| Market Cap |
19,788,234,752 |
Cash |
235,400,000 |
| Debt |
1,995,200,000 |
Recommendation |
hold |
| RSI |
44.3 |
MACD |
-4.23 |
| Signal |
-0.76 |
Histogram |
-3.47 |
| Revenue Growth |
26.0% |
EPS Growth |
42.0% |
| Gross Margin |
28.0% |
ROE |
12.0% |
| Target Price |
408.62 |
Analysts |
8 |
|
|
3.0
|
RYAN
|
Ryan Specialty Holdings, Inc.
|
42.32
|
buy
|
7%
/
3%
|
46%
|
49.1
↑
|
-0.19
|
0.03
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Specialty |
| Market Cap |
17,109,566,464 |
Cash |
140,119,008 |
| Debt |
3,807,566,080 |
Recommendation |
buy |
| RSI |
49.1 |
MACD |
0.36 |
| Signal |
0.54 |
Histogram |
-0.19 |
| Revenue Growth |
7.0% |
EPS Growth |
-14.0% |
| Gross Margin |
41.0% |
ROE |
22.0% |
| Target Price |
50.84 |
Analysts |
16 |
|
|
-2.0
|
RYN
|
Rayonier Inc. REIT
|
20.81
|
none
|
272%
/
8%
|
30%
|
43.4
↑
|
-0.09
|
-0.02
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Specialty |
| Market Cap |
6,098,705,408 |
Cash |
411,760,000 |
| Debt |
1,891,550,976 |
Recommendation |
none |
| RSI |
43.4 |
MACD |
-0.21 |
| Signal |
-0.12 |
Histogram |
-0.09 |
| Revenue Growth |
272.0% |
EPS Growth |
-98.0% |
| Gross Margin |
25.0% |
ROE |
2.0% |
| Target Price |
24.83 |
Analysts |
6 |
|
|
1.0
|
RYZ
|
Ryerson Holding Corporation
|
25.34
|
none
|
72%
/
-1%
|
50%
|
43.0
↑
|
-0.19
|
0.01
|
▼ |
| Sector |
Industrials |
Industry |
Metal Fabrication |
| Market Cap |
1,314,073,856 |
Cash |
41,900,000 |
| Debt |
1,348,999,936 |
Recommendation |
none |
| RSI |
43.0 |
MACD |
-0.83 |
| Signal |
-0.64 |
Histogram |
-0.19 |
| Revenue Growth |
72.0% |
EPS Growth |
406.0% |
| Gross Margin |
17.0% |
ROE |
-3.0% |
| Target Price |
29.00 |
Analysts |
1 |
|
|
3.0
|
SAFE
|
Safehold Inc. New
|
15.20
|
hold
|
20%
/
27%
|
60%
|
42.7
↑
|
-0.00
|
0.03
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Diversified |
| Market Cap |
1,088,446,208 |
Cash |
15,922,000 |
| Debt |
4,659,251,200 |
Recommendation |
hold |
| RSI |
42.7 |
MACD |
-0.20 |
| Signal |
-0.20 |
Histogram |
-0.00 |
| Revenue Growth |
20.0% |
EPS Growth |
8.0% |
| Gross Margin |
93.0% |
ROE |
5.0% |
| Target Price |
18.70 |
Analysts |
10 |
|
|
-14.0
|
SAFX
|
XCF Global, Inc.
|
0.38
|
none
|
-90%
/
0%
|
18%
|
47.9
↑
|
-0.00
|
-0.14
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Renewable |
| Market Cap |
147,524,352 |
Cash |
329,084 |
| Debt |
257,427,280 |
Recommendation |
none |
| RSI |
47.9 |
MACD |
-0.02 |
| Signal |
-0.01 |
Histogram |
-0.00 |
| Revenue Growth |
-90.0% |
EPS Growth |
N/A |
| Gross Margin |
-17.0% |
ROE |
-246.0% |
| Target Price |
1.10 |
Analysts |
2 |
|
|
16.0
|
SCHL
|
Scholastic Corporation
|
38.44
|
none
|
-6%
/
4%
|
62%
|
34.8
↑
|
-0.19
|
0.16
|
▼ |
| Sector |
Communication Services |
Industry |
Publishing |
| Market Cap |
734,885,952 |
Cash |
134,900,000 |
| Debt |
419,500,000 |
Recommendation |
none |
| RSI |
34.8 |
MACD |
-1.12 |
| Signal |
-0.93 |
Histogram |
-0.19 |
| Revenue Growth |
-6.0% |
EPS Growth |
-24.0% |
| Gross Margin |
56.0% |
ROE |
7.0% |
| Target Price |
42.00 |
Analysts |
2 |
|
|
-29.0
|
SEAT
|
Vivid Seats Inc.
|
6.04
|
buy
|
-10%
/
-60%
|
6%
|
37.7
↑
|
-0.13
|
-0.29
|
▼ |
| Sector |
Communication Services |
Industry |
Internet Content & Information |
| Market Cap |
67,671,992 |
Cash |
136,676,000 |
| Debt |
401,025,984 |
Recommendation |
buy |
| RSI |
37.7 |
MACD |
-0.32 |
| Signal |
-0.19 |
Histogram |
-0.13 |
| Revenue Growth |
-10.0% |
EPS Growth |
N/A |
| Gross Margin |
68.0% |
ROE |
-396.0% |
| Target Price |
11.68 |
Analysts |
7 |
|
|
-14.0
|
SEB
|
Seaboard Corporation
|
4123.38
|
none
|
18%
/
6%
|
33%
|
41.3
↑
|
-20.46
|
-0.14
|
▼ |
| Sector |
Industrials |
Industry |
Conglomerates |
| Market Cap |
3,748,052,992 |
Cash |
1,207,000,064 |
| Debt |
1,972,000,000 |
Recommendation |
none |
| RSI |
41.3 |
MACD |
-125.81 |
| Signal |
-105.35 |
Histogram |
-20.46 |
| Revenue Growth |
18.0% |
EPS Growth |
52.0% |
| Gross Margin |
8.0% |
ROE |
12.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
-29.0
|
SEDG
|
SolarEdge Technologies, Inc.
|
32.49
|
hold
|
20%
/
-20%
|
8%
|
41.9
↑
|
0.86
|
-0.29
|
▼ |
| Sector |
Technology |
Industry |
Solar |
| Market Cap |
1,932,523,776 |
Cash |
546,942,016 |
| Debt |
407,352,992 |
Recommendation |
hold |
| RSI |
41.9 |
MACD |
-3.25 |
| Signal |
-4.11 |
Histogram |
0.86 |
| Revenue Growth |
20.0% |
EPS Growth |
N/A |
| Gross Margin |
21.0% |
ROE |
-58.0% |
| Target Price |
39.15 |
Analysts |
20 |
|
|
8.0
|
SGC
|
Superior Group of Companies, In
|
12.19
|
none
|
3%
/
1%
|
69%
|
43.1
↑
|
-0.10
|
0.08
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Apparel Manufacturing |
| Market Cap |
194,212,560 |
Cash |
22,787,000 |
| Debt |
93,267,000 |
Recommendation |
none |
| RSI |
43.1 |
MACD |
-0.18 |
| Signal |
-0.08 |
Histogram |
-0.10 |
| Revenue Growth |
3.0% |
EPS Growth |
-20.0% |
| Gross Margin |
38.0% |
ROE |
4.0% |
| Target Price |
18.00 |
Analysts |
3 |
|
|
-7.0
|
SGRY
|
Surgery Partners, Inc.
|
14.60
|
none
|
3%
/
-3%
|
27%
|
48.7
↑
|
-0.01
|
-0.07
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
1,792,270,848 |
Cash |
216,700,000 |
| Debt |
4,067,000,064 |
Recommendation |
none |
| RSI |
48.7 |
MACD |
-0.39 |
| Signal |
-0.38 |
Histogram |
-0.01 |
| Revenue Growth |
3.0% |
EPS Growth |
N/A |
| Gross Margin |
23.0% |
ROE |
2.0% |
| Target Price |
18.73 |
Analysts |
11 |
|
|
11.0
|
SKT
|
Tanger Inc.
|
38.04
|
hold
|
12%
/
20%
|
66%
|
39.8
↑
|
-0.07
|
0.11
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
4,510,315,520 |
Cash |
181,287,008 |
| Debt |
1,952,108,032 |
Recommendation |
hold |
| RSI |
39.8 |
MACD |
-0.51 |
| Signal |
-0.44 |
Histogram |
-0.07 |
| Revenue Growth |
12.0% |
EPS Growth |
11.0% |
| Gross Margin |
73.0% |
ROE |
19.0% |
| Target Price |
41.36 |
Analysts |
11 |
|
|
23.0
|
SKWD
|
Skyward Specialty Insurance Gro
|
57.42
|
buy
|
53%
/
11%
|
66%
|
45.5
↑
|
-0.29
|
0.23
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Property & Casualty |
| Market Cap |
2,363,255,296 |
Cash |
611,854,976 |
| Debt |
437,204,992 |
Recommendation |
buy |
| RSI |
45.5 |
MACD |
-0.56 |
| Signal |
-0.27 |
Histogram |
-0.29 |
| Revenue Growth |
53.0% |
EPS Growth |
15.0% |
| Gross Margin |
30.0% |
ROE |
17.0% |
| Target Price |
70.55 |
Analysts |
11 |
|
|
-45.0
|
SLSN
|
Solesence, Inc.
|
0.90
|
none
|
-25%
/
-5%
|
7%
|
45.4
↑
|
-0.01
|
-0.45
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Household & Personal Products |
| Market Cap |
67,114,696 |
Cash |
1,046,000 |
| Debt |
22,700,000 |
Recommendation |
none |
| RSI |
45.4 |
MACD |
-0.00 |
| Signal |
0.00 |
Histogram |
-0.01 |
| Revenue Growth |
-25.0% |
EPS Growth |
N/A |
| Gross Margin |
25.0% |
ROE |
-19.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
2.0
|
SMA
|
SmartStop Self Storage REIT, In
|
32.50
|
buy
|
11%
/
10%
|
41%
|
35.6
↑
|
-0.23
|
0.02
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Industrial |
| Market Cap |
1,829,388,672 |
Cash |
38,185,000 |
| Debt |
1,119,645,056 |
Recommendation |
buy |
| RSI |
35.6 |
MACD |
-0.14 |
| Signal |
0.09 |
Histogram |
-0.23 |
| Revenue Growth |
11.0% |
EPS Growth |
N/A |
| Gross Margin |
66.0% |
ROE |
2.0% |
| Target Price |
36.89 |
Analysts |
11 |
|
|
20.0
|
SNDA
|
Sonida Senior Living, Inc.
|
37.80
|
none
|
137%
/
-25%
|
70%
|
41.9
↑
|
-0.25
|
0.20
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Care Facilities |
| Market Cap |
1,799,877,760 |
Cash |
49,051,000 |
| Debt |
1,571,552,000 |
Recommendation |
none |
| RSI |
41.9 |
MACD |
-0.36 |
| Signal |
-0.11 |
Histogram |
-0.25 |
| Revenue Growth |
137.0% |
EPS Growth |
N/A |
| Gross Margin |
27.0% |
ROE |
-25.0% |
| Target Price |
47.50 |
Analysts |
6 |
|
|
6.0
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
20.10
|
strong_buy
|
92%
/
-88%
|
58%
|
49.8
↑
|
0.06
|
0.06
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
1,744,865,152 |
Cash |
554,265,984 |
| Debt |
589,382,016 |
Recommendation |
strong_buy |
| RSI |
49.8 |
MACD |
-0.21 |
| Signal |
-0.26 |
Histogram |
0.06 |
| Revenue Growth |
92.0% |
EPS Growth |
N/A |
| Gross Margin |
-8.0% |
ROE |
-256.0% |
| Target Price |
37.55 |
Analysts |
11 |
|
|
1.0
|
SNFCA
|
Security National Financial Cor
|
8.72
|
none
|
-6%
/
10%
|
51%
|
37.9
↑
|
-0.03
|
0.01
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Life |
| Market Cap |
229,188,688 |
Cash |
167,011,872 |
| Debt |
122,319,440 |
Recommendation |
none |
| RSI |
37.9 |
MACD |
-0.19 |
| Signal |
-0.17 |
Histogram |
-0.03 |
| Revenue Growth |
-6.0% |
EPS Growth |
6.0% |
| Gross Margin |
51.0% |
ROE |
8.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
10.0
|
SPFI
|
South Plains Financial, Inc.
|
43.71
|
none
|
23%
/
29%
|
80%
|
43.9
↑
|
-0.23
|
0.10
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
822,515,264 |
Cash |
796,648,000 |
| Debt |
60,539,000 |
Recommendation |
none |
| RSI |
43.9 |
MACD |
-0.11 |
| Signal |
0.12 |
Histogram |
-0.23 |
| Revenue Growth |
23.0% |
EPS Growth |
12.0% |
| Gross Margin |
0.0% |
ROE |
12.0% |
| Target Price |
50.75 |
Analysts |
4 |
|
|
18.0
|
SRBK
|
SR Bancorp, Inc.
|
19.50
|
none
|
9%
/
10%
|
86%
|
45.8
↑
|
-0.09
|
0.18
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
141,741,632 |
Cash |
71,461,000 |
| Debt |
67,785,000 |
Recommendation |
none |
| RSI |
45.8 |
MACD |
-0.01 |
| Signal |
0.08 |
Histogram |
-0.09 |
| Revenue Growth |
9.0% |
EPS Growth |
-53.0% |
| Gross Margin |
0.0% |
ROE |
2.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
-64.0
|
SSTK
|
Shutterstock, Inc.
|
5.75
|
none
|
-17%
/
-23%
|
2%
|
42.0
↑
|
0.19
|
-0.64
|
▼ |
| Sector |
Communication Services |
Industry |
Internet Content & Information |
| Market Cap |
220,577,664 |
Cash |
133,208,000 |
| Debt |
297,268,992 |
Recommendation |
none |
| RSI |
42.0 |
MACD |
-0.53 |
| Signal |
-0.72 |
Histogram |
0.19 |
| Revenue Growth |
-17.0% |
EPS Growth |
N/A |
| Gross Margin |
57.0% |
ROE |
-43.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
-8.0
|
STAA
|
STAAR Surgical Company
|
23.52
|
hold
|
111%
/
1%
|
43%
|
45.5
↑
|
-0.03
|
-0.08
|
▼ |
| Sector |
Healthcare |
Industry |
Medical Instruments & Supplies |
| Market Cap |
1,108,683,520 |
Cash |
181,488,992 |
| Debt |
35,941,000 |
Recommendation |
hold |
| RSI |
45.5 |
MACD |
-0.70 |
| Signal |
-0.67 |
Histogram |
-0.03 |
| Revenue Growth |
111.0% |
EPS Growth |
N/A |
| Gross Margin |
77.0% |
ROE |
1.0% |
| Target Price |
27.90 |
Analysts |
10 |
|
|
24.0
|
STLD
|
Steel Dynamics, Inc.
|
234.09
|
buy
|
33%
/
8%
|
69%
|
42.8
↑
|
-1.89
|
0.24
|
▼ |
| Sector |
Basic Materials |
Industry |
Steel |
| Market Cap |
33,634,086,912 |
Cash |
567,708,032 |
| Debt |
4,393,537,024 |
Recommendation |
buy |
| RSI |
42.8 |
MACD |
-4.74 |
| Signal |
-2.84 |
Histogram |
-1.89 |
| Revenue Growth |
33.0% |
EPS Growth |
84.0% |
| Gross Margin |
15.0% |
ROE |
18.0% |
| Target Price |
271.21 |
Analysts |
14 |
|
|
11.0
|
STRW
|
Strawberry Fields REIT, Inc.
|
13.60
|
strong_buy
|
6%
/
5%
|
73%
|
45.2
↑
|
-0.03
|
0.11
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Healthcare Facilities |
| Market Cap |
769,794,176 |
Cash |
42,153,000 |
| Debt |
803,305,024 |
Recommendation |
strong_buy |
| RSI |
45.2 |
MACD |
-0.06 |
| Signal |
-0.03 |
Histogram |
-0.03 |
| Revenue Growth |
6.0% |
EPS Growth |
2.0% |
| Gross Margin |
90.0% |
ROE |
73.0% |
| Target Price |
15.64 |
Analysts |
7 |
|
|
77.0
|
STRZ
|
Starz Entertainment Corp.
|
26.52
|
buy
|
-4%
/
-25%
|
83%
|
48.9
↑
|
0.06
|
0.77
|
▼ |
| Sector |
Communication Services |
Industry |
Entertainment |
| Market Cap |
475,195,776 |
Cash |
59,600,000 |
| Debt |
787,200,000 |
Recommendation |
buy |
| RSI |
48.9 |
MACD |
0.28 |
| Signal |
0.22 |
Histogram |
0.06 |
| Revenue Growth |
-4.0% |
EPS Growth |
N/A |
| Gross Margin |
54.0% |
ROE |
N/A |
| Target Price |
34.67 |
Analysts |
9 |
|
|
-6.0
|
STZ
|
Constellation Brands, Inc.
|
130.63
|
none
|
-3%
/
20%
|
14%
|
44.0
↑
|
-0.33
|
-0.06
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Beverages - Brewers |
| Market Cap |
22,322,421,760 |
Cash |
96,600,000 |
| Debt |
10,533,799,936 |
Recommendation |
none |
| RSI |
44.0 |
MACD |
-0.30 |
| Signal |
0.03 |
Histogram |
-0.33 |
| Revenue Growth |
-3.0% |
EPS Growth |
31.0% |
| Gross Margin |
53.0% |
ROE |
24.0% |
| Target Price |
170.83 |
Analysts |
23 |
|
|
-2.0
|
SUI
|
Sun Communities, Inc.
|
121.44
|
buy
|
0%
/
-37%
|
28%
|
48.5
↑
|
0.04
|
-0.02
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Residential |
| Market Cap |
15,531,273,216 |
Cash |
165,200,000 |
| Debt |
4,074,800,128 |
Recommendation |
buy |
| RSI |
48.5 |
MACD |
0.43 |
| Signal |
0.38 |
Histogram |
0.04 |
| Revenue Growth |
0.0% |
EPS Growth |
N/A |
| Gross Margin |
54.0% |
ROE |
2.0% |
| Target Price |
139.00 |
Analysts |
19 |
|
|
8.0
|
SWX
|
Southwest Gas Holdings, Inc.
|
89.35
|
none
|
-10%
/
31%
|
81%
|
46.2
↑
|
-0.26
|
0.08
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Gas |
| Market Cap |
6,454,925,824 |
Cash |
270,518,016 |
| Debt |
3,509,859,072 |
Recommendation |
none |
| RSI |
46.2 |
MACD |
-0.32 |
| Signal |
-0.06 |
Histogram |
-0.26 |
| Revenue Growth |
-10.0% |
EPS Growth |
N/A |
| Gross Margin |
54.0% |
ROE |
7.0% |
| Target Price |
102.71 |
Analysts |
7 |
|
|
6.0
|
SYY
|
Sysco Corporation
|
82.11
|
buy
|
5%
/
2%
|
64%
|
45.8
↑
|
-0.27
|
0.06
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Food Distribution |
| Market Cap |
39,257,128,960 |
Cash |
1,787,000,064 |
| Debt |
15,052,000,256 |
Recommendation |
buy |
| RSI |
45.8 |
MACD |
-0.14 |
| Signal |
0.14 |
Histogram |
-0.27 |
| Revenue Growth |
5.0% |
EPS Growth |
5.0% |
| Gross Margin |
18.0% |
ROE |
78.0% |
| Target Price |
90.31 |
Analysts |
13 |
|
|
-18.0
|
TARA
|
Protara Therapeutics, Inc.
|
3.90
|
none
|
N/A
/
0%
|
19%
|
45.7
↑
|
0.00
|
-0.18
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
225,744,768 |
Cash |
142,494,000 |
| Debt |
2,749,000 |
Recommendation |
none |
| RSI |
45.7 |
MACD |
-0.04 |
| Signal |
-0.04 |
Histogram |
0.00 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-46.0% |
| Target Price |
25.71 |
Analysts |
7 |
|
|
-9.0
|
TCI
|
Transcontinental Realty Investo
|
36.61
|
none
|
6%
/
16%
|
14%
|
42.4
↑
|
0.17
|
-0.09
|
▼ |
| Sector |
Real Estate |
Industry |
Real Estate Services |
| Market Cap |
317,091,104 |
Cash |
10,703,000 |
| Debt |
214,486,000 |
Recommendation |
none |
| RSI |
42.4 |
MACD |
-0.88 |
| Signal |
-1.05 |
Histogram |
0.17 |
| Revenue Growth |
6.0% |
EPS Growth |
N/A |
| Gross Margin |
38.0% |
ROE |
1.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
38.0
|
TECX
|
Tectonic Therapeutic, Inc.
|
31.22
|
strong_buy
|
N/A
/
0%
|
71%
|
44.4
↑
|
-0.47
|
0.38
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
696,348,416 |
Cash |
227,068,000 |
| Debt |
4,399,000 |
Recommendation |
strong_buy |
| RSI |
44.4 |
MACD |
0.58 |
| Signal |
1.04 |
Histogram |
-0.47 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-34.0% |
| Target Price |
77.56 |
Analysts |
9 |
|
|
-4.0
|
TG
|
Tredegar Corporation
|
7.71
|
none
|
21%
/
4%
|
35%
|
46.1
↑
|
-0.04
|
-0.04
|
▼ |
| Sector |
Industrials |
Industry |
Metal Fabrication |
| Market Cap |
271,639,872 |
Cash |
17,179,000 |
| Debt |
60,688,000 |
Recommendation |
none |
| RSI |
46.1 |
MACD |
-0.01 |
| Signal |
0.03 |
Histogram |
-0.04 |
| Revenue Growth |
21.0% |
EPS Growth |
258.0% |
| Gross Margin |
15.0% |
ROE |
15.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
-6.0
|
TRDA
|
Entrada Therapeutics, Inc.
|
7.07
|
none
|
-54%
/
0%
|
18%
|
48.2
↑
|
-0.05
|
-0.06
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
272,556,672 |
Cash |
223,004,992 |
| Debt |
48,544,000 |
Recommendation |
none |
| RSI |
48.2 |
MACD |
0.07 |
| Signal |
0.12 |
Histogram |
-0.05 |
| Revenue Growth |
-54.0% |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-54.0% |
| Target Price |
19.00 |
Analysts |
4 |
|
|
8.0
|
TRNO
|
Terreno Realty Corporation
|
66.45
|
buy
|
11%
/
77%
|
59%
|
35.2
↑
|
-0.26
|
0.08
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Industrial |
| Market Cap |
7,256,332,800 |
Cash |
51,208,000 |
| Debt |
948,291,008 |
Recommendation |
buy |
| RSI |
35.2 |
MACD |
-0.79 |
| Signal |
-0.53 |
Histogram |
-0.26 |
| Revenue Growth |
11.0% |
EPS Growth |
-40.0% |
| Gross Margin |
76.0% |
ROE |
9.0% |
| Target Price |
73.76 |
Analysts |
17 |
|
|
3.0
|
TRS
|
TriMas Corporation
|
38.91
|
none
|
2%
/
136%
|
57%
|
43.5
↑
|
0.04
|
0.03
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Packaging & Containers |
| Market Cap |
1,418,094,080 |
Cash |
1,242,480,000 |
| Debt |
437,769,984 |
Recommendation |
none |
| RSI |
43.5 |
MACD |
-0.30 |
| Signal |
-0.34 |
Histogram |
0.04 |
| Revenue Growth |
2.0% |
EPS Growth |
-10.0% |
| Gross Margin |
21.0% |
ROE |
8.0% |
| Target Price |
45.00 |
Analysts |
2 |
|
|
26.0
|
TSHA
|
Taysha Gene Therapies, Inc.
|
5.70
|
strong_buy
|
N/A
/
0%
|
69%
|
42.5
↑
|
-0.06
|
0.26
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
1,880,059,520 |
Cash |
455,407,008 |
| Debt |
56,714,000 |
Recommendation |
strong_buy |
| RSI |
42.5 |
MACD |
-0.06 |
| Signal |
0.01 |
Histogram |
-0.06 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
100.0% |
ROE |
-47.0% |
| Target Price |
13.33 |
Analysts |
12 |
|
|
-51.0
|
TTD
|
The Trade Desk, Inc.
|
13.78
|
hold
|
3%
/
14%
|
2%
|
39.2
↑
|
0.18
|
-0.51
|
▼ |
| Sector |
Communication Services |
Industry |
Advertising Agencies |
| Market Cap |
6,376,273,920 |
Cash |
1,485,332,992 |
| Debt |
434,110,016 |
Recommendation |
hold |
| RSI |
39.2 |
MACD |
-1.04 |
| Signal |
-1.22 |
Histogram |
0.18 |
| Revenue Growth |
3.0% |
EPS Growth |
-24.0% |
| Gross Margin |
77.0% |
ROE |
15.0% |
| Target Price |
13.39 |
Analysts |
30 |
|
|
13.0
|
TYRA
|
Tyra Biosciences, Inc.
|
25.30
|
strong_buy
|
N/A
/
0%
|
49%
|
38.7
↑
|
0.08
|
0.13
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
1,488,342,912 |
Cash |
353,944,000 |
| Debt |
5,582,000 |
Recommendation |
strong_buy |
| RSI |
38.7 |
MACD |
-1.11 |
| Signal |
-1.18 |
Histogram |
0.08 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-45.0% |
| Target Price |
50.82 |
Analysts |
11 |
|
|
4.0
|
UE
|
Urban Edge Properties
|
21.38
|
buy
|
8%
/
14%
|
59%
|
38.5
↑
|
-0.01
|
0.04
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Retail |
| Market Cap |
2,945,127,680 |
Cash |
58,264,000 |
| Debt |
1,744,205,952 |
Recommendation |
buy |
| RSI |
38.5 |
MACD |
-0.33 |
| Signal |
-0.32 |
Histogram |
-0.01 |
| Revenue Growth |
8.0% |
EPS Growth |
-69.0% |
| Gross Margin |
65.0% |
ROE |
5.0% |
| Target Price |
24.29 |
Analysts |
7 |
|
|
23.0
|
UHAL
|
U-Haul Holding Company
|
67.50
|
none
|
3%
/
1%
|
77%
|
33.7
↑
|
-0.92
|
0.23
|
▼ |
| Sector |
Industrials |
Industry |
Rental & Leasing Services |
| Market Cap |
13,408,947,200 |
Cash |
1,097,336,064 |
| Debt |
8,145,006,080 |
Recommendation |
none |
| RSI |
33.7 |
MACD |
-0.60 |
| Signal |
0.31 |
Histogram |
-0.92 |
| Revenue Growth |
3.0% |
EPS Growth |
-14.0% |
| Gross Margin |
29.0% |
ROE |
1.0% |
| Target Price |
87.62 |
Analysts |
3 |
|
|
4.0
|
UHT
|
Universal Health Realty Income
|
41.11
|
none
|
1%
/
19%
|
62%
|
43.8
↑
|
0.02
|
0.04
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Healthcare Facilities |
| Market Cap |
576,239,424 |
Cash |
9,419,000 |
| Debt |
395,099,008 |
Recommendation |
none |
| RSI |
43.8 |
MACD |
-0.33 |
| Signal |
-0.35 |
Histogram |
0.02 |
| Revenue Growth |
1.0% |
EPS Growth |
33.0% |
| Gross Margin |
94.0% |
ROE |
12.0% |
| Target Price |
44.00 |
Analysts |
1 |
|
|
3.0
|
UNB
|
Union Bankshares, Inc.
|
23.76
|
none
|
13%
/
21%
|
61%
|
47.7
↑
|
-0.05
|
0.03
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
116,722,488 |
Cash |
38,941,000 |
| Debt |
353,399,008 |
Recommendation |
none |
| RSI |
47.7 |
MACD |
-0.10 |
| Signal |
-0.06 |
Histogram |
-0.05 |
| Revenue Growth |
13.0% |
EPS Growth |
15.0% |
| Gross Margin |
0.0% |
ROE |
15.0% |
| Target Price |
N/A |
Analysts |
N/A |
|
|
30.0
|
UNF
|
Unifirst Corporation
|
277.48
|
none
|
4%
/
5%
|
84%
|
35.0
↑
|
-1.80
|
0.30
|
▼ |
| Sector |
Industrials |
Industry |
Specialty Business Services |
| Market Cap |
5,097,566,720 |
Cash |
168,876,000 |
| Debt |
85,048,000 |
Recommendation |
none |
| RSI |
35.0 |
MACD |
-0.87 |
| Signal |
0.94 |
Histogram |
-1.80 |
| Revenue Growth |
4.0% |
EPS Growth |
-48.0% |
| Gross Margin |
37.0% |
ROE |
5.0% |
| Target Price |
273.33 |
Analysts |
3 |
|
|
13.0
|
UNFI
|
United Natural Foods, Inc.
|
44.64
|
none
|
-4%
/
0%
|
60%
|
38.0
↑
|
-0.28
|
0.13
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Food Distribution |
| Market Cap |
2,771,776,512 |
Cash |
43,000,000 |
| Debt |
3,153,999,872 |
Recommendation |
none |
| RSI |
38.0 |
MACD |
-0.76 |
| Signal |
-0.48 |
Histogram |
-0.28 |
| Revenue Growth |
-4.0% |
EPS Growth |
N/A |
| Gross Margin |
13.0% |
ROE |
-2.0% |
| Target Price |
49.38 |
Analysts |
8 |
|
|
-5.0
|
UPBD
|
Upbound Group, Inc.
|
18.42
|
none
|
0%
/
2%
|
33%
|
39.9
↑
|
-0.06
|
-0.05
|
▼ |
| Sector |
Technology |
Industry |
Software - Application |
| Market Cap |
1,120,514,560 |
Cash |
105,302,000 |
| Debt |
1,708,210,048 |
Recommendation |
none |
| RSI |
39.9 |
MACD |
-0.38 |
| Signal |
-0.32 |
Histogram |
-0.06 |
| Revenue Growth |
0.0% |
EPS Growth |
42.0% |
| Gross Margin |
49.0% |
ROE |
13.0% |
| Target Price |
28.25 |
Analysts |
6 |
|
|
84.0
|
URGN
|
UroGen Pharma Ltd.
|
43.39
|
strong_buy
|
199%
/
-52%
|
80%
|
45.7
↑
|
-0.87
|
0.84
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
2,132,170,112 |
Cash |
107,975,000 |
| Debt |
196,128,000 |
Recommendation |
strong_buy |
| RSI |
45.7 |
MACD |
0.91 |
| Signal |
1.78 |
Histogram |
-0.87 |
| Revenue Growth |
199.0% |
EPS Growth |
N/A |
| Gross Margin |
91.0% |
ROE |
N/A |
| Target Price |
60.00 |
Analysts |
8 |
|
|
5.0
|
UTHR
|
United Therapeutics Corporation
|
512.70
|
buy
|
-2%
/
42%
|
61%
|
45.4
↑
|
0.74
|
0.05
|
▼ |
| Sector |
Healthcare |
Industry |
Drug Manufacturers - Specialty & Generic |
| Market Cap |
22,108,436,480 |
Cash |
2,662,299,904 |
| Debt |
0 |
Recommendation |
buy |
| RSI |
45.4 |
MACD |
-3.72 |
| Signal |
-4.46 |
Histogram |
0.74 |
| Revenue Growth |
-2.0% |
EPS Growth |
13.0% |
| Gross Margin |
86.0% |
ROE |
19.0% |
| Target Price |
664.33 |
Analysts |
12 |
|
|
-11.0
|
UVV
|
Universal Corporation
|
46.13
|
none
|
-12%
/
1%
|
14%
|
40.9
↑
|
0.20
|
-0.11
|
▼ |
| Sector |
Consumer Defensive |
Industry |
Tobacco |
| Market Cap |
1,138,892,032 |
Cash |
173,592,992 |
| Debt |
1,217,208,960 |
Recommendation |
none |
| RSI |
40.9 |
MACD |
-1.43 |
| Signal |
-1.62 |
Histogram |
0.20 |
| Revenue Growth |
-12.0% |
EPS Growth |
N/A |
| Gross Margin |
17.0% |
ROE |
2.0% |
| Target Price |
67.00 |
Analysts |
1 |
|
|
16.0
|
VCEL
|
Vericel Corporation
|
40.50
|
strong_buy
|
22%
/
8%
|
59%
|
35.9
↑
|
-0.43
|
0.16
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
2,096,910,976 |
Cash |
162,458,000 |
| Debt |
93,133,000 |
Recommendation |
strong_buy |
| RSI |
35.9 |
MACD |
-1.02 |
| Signal |
-0.60 |
Histogram |
-0.43 |
| Revenue Growth |
22.0% |
EPS Growth |
N/A |
| Gross Margin |
75.0% |
ROE |
7.0% |
| Target Price |
60.57 |
Analysts |
7 |
|
|
7.0
|
VCYT
|
Veracyte, Inc.
|
43.43
|
buy
|
16%
/
20%
|
44%
|
42.2
↑
|
0.48
|
0.07
|
▼ |
| Sector |
Healthcare |
Industry |
Diagnostics & Research |
| Market Cap |
3,484,134,144 |
Cash |
485,232,000 |
| Debt |
40,107,000 |
Recommendation |
buy |
| RSI |
42.2 |
MACD |
-2.16 |
| Signal |
-2.64 |
Histogram |
0.48 |
| Revenue Growth |
16.0% |
EPS Growth |
N/A |
| Gross Margin |
74.0% |
ROE |
9.0% |
| Target Price |
57.82 |
Analysts |
11 |
|
|
7.0
|
VKTX
|
Viking Therapeutics, Inc.
|
33.67
|
strong_buy
|
N/A
/
0%
|
56%
|
47.9
↑
|
0.02
|
0.07
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
3,751,558,400 |
Cash |
501,663,008 |
| Debt |
4,086,000 |
Recommendation |
strong_buy |
| RSI |
47.9 |
MACD |
-0.29 |
| Signal |
-0.31 |
Histogram |
0.02 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
0.0% |
ROE |
-89.0% |
| Target Price |
92.39 |
Analysts |
19 |
|
|
-18.0
|
VST
|
Vistra Corp.
|
138.08
|
strong_buy
|
-6%
/
12%
|
4%
|
41.4
↑
|
0.08
|
-0.18
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Independent Power Producers |
| Market Cap |
46,012,227,584 |
Cash |
435,000,000 |
| Debt |
20,508,000,256 |
Recommendation |
strong_buy |
| RSI |
41.4 |
MACD |
-3.64 |
| Signal |
-3.72 |
Histogram |
0.08 |
| Revenue Growth |
-6.0% |
EPS Growth |
-6.0% |
| Gross Margin |
38.0% |
ROE |
43.0% |
| Target Price |
217.42 |
Analysts |
19 |
|
|
-9.0
|
VTEX
|
VTEX
|
3.61
|
buy
|
10%
/
12%
|
42%
|
39.4
↑
|
-0.02
|
-0.09
|
▼ |
| Sector |
Technology |
Industry |
Software - Application |
| Market Cap |
595,195,648 |
Cash |
185,963,008 |
| Debt |
7,095,000 |
Recommendation |
buy |
| RSI |
39.4 |
MACD |
-0.13 |
| Signal |
-0.11 |
Histogram |
-0.02 |
| Revenue Growth |
10.0% |
EPS Growth |
262.0% |
| Gross Margin |
79.0% |
ROE |
13.0% |
| Target Price |
5.68 |
Analysts |
9 |
|
|
18.0
|
VTR
|
Ventas, Inc.
|
92.07
|
buy
|
22%
/
4%
|
76%
|
49.2
↑
|
-0.01
|
0.18
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Healthcare Facilities |
| Market Cap |
47,093,604,352 |
Cash |
198,956,000 |
| Debt |
12,918,999,040 |
Recommendation |
buy |
| RSI |
49.2 |
MACD |
0.04 |
| Signal |
0.05 |
Histogram |
-0.01 |
| Revenue Growth |
22.0% |
EPS Growth |
-7.0% |
| Gross Margin |
40.0% |
ROE |
2.0% |
| Target Price |
100.45 |
Analysts |
22 |
|
|
15.0
|
VVX
|
V2X, Inc.
|
77.45
|
none
|
16%
/
2%
|
65%
|
43.7
↑
|
-0.56
|
0.15
|
▼ |
| Sector |
Industrials |
Industry |
Aerospace & Defense |
| Market Cap |
2,435,220,992 |
Cash |
210,312,992 |
| Debt |
1,106,418,048 |
Recommendation |
none |
| RSI |
43.7 |
MACD |
-1.04 |
| Signal |
-0.48 |
Histogram |
-0.56 |
| Revenue Growth |
16.0% |
EPS Growth |
16.0% |
| Gross Margin |
8.0% |
ROE |
8.0% |
| Target Price |
89.18 |
Analysts |
11 |
|
|
15.0
|
WABC
|
Westamerica Bancorporation
|
58.17
|
none
|
-3%
/
44%
|
79%
|
43.3
↑
|
-0.14
|
0.15
|
▼ |
| Sector |
Financial Services |
Industry |
Banks - Regional |
| Market Cap |
1,342,064,640 |
Cash |
302,188,992 |
| Debt |
154,010,000 |
Recommendation |
none |
| RSI |
43.3 |
MACD |
-0.30 |
| Signal |
-0.16 |
Histogram |
-0.14 |
| Revenue Growth |
-3.0% |
EPS Growth |
4.0% |
| Gross Margin |
0.0% |
ROE |
12.0% |
| Target Price |
64.00 |
Analysts |
1 |
|
|
-2.0
|
WEC
|
WEC Energy Group, Inc.
|
106.20
|
buy
|
3%
/
17%
|
31%
|
40.4
↑
|
-0.08
|
-0.02
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
34,611,720,192 |
Cash |
50,000,000 |
| Debt |
23,023,200,256 |
Recommendation |
buy |
| RSI |
40.4 |
MACD |
-1.18 |
| Signal |
-1.10 |
Histogram |
-0.08 |
| Revenue Growth |
3.0% |
EPS Growth |
20.0% |
| Gross Margin |
42.0% |
ROE |
12.0% |
| Target Price |
121.62 |
Analysts |
17 |
|
|
-48.0
|
WING
|
Wingstop Inc.
|
109.60
|
buy
|
6%
/
16%
|
0%
|
36.8
↑
|
0.44
|
-0.48
|
▼ |
| Sector |
Consumer Cyclical |
Industry |
Restaurants |
| Market Cap |
3,094,208,512 |
Cash |
127,455,000 |
| Debt |
1,272,475,008 |
Recommendation |
buy |
| RSI |
36.8 |
MACD |
-6.61 |
| Signal |
-7.04 |
Histogram |
0.44 |
| Revenue Growth |
6.0% |
EPS Growth |
20.0% |
| Gross Margin |
49.0% |
ROE |
N/A |
| Target Price |
202.89 |
Analysts |
27 |
|
|
2.0
|
WPC
|
W. P. Carey Inc. REIT
|
70.16
|
buy
|
18%
/
36%
|
57%
|
38.5
↑
|
-0.11
|
0.02
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Diversified |
| Market Cap |
16,062,689,280 |
Cash |
167,252,000 |
| Debt |
8,852,117,504 |
Recommendation |
buy |
| RSI |
38.5 |
MACD |
-0.65 |
| Signal |
-0.54 |
Histogram |
-0.11 |
| Revenue Growth |
18.0% |
EPS Growth |
256.0% |
| Gross Margin |
94.0% |
ROE |
8.0% |
| Target Price |
80.00 |
Analysts |
13 |
|
|
-2.0
|
WRB
|
W.R. Berkley Corporation
|
67.72
|
hold
|
1%
/
13%
|
35%
|
36.6
↑
|
-0.27
|
-0.02
|
▼ |
| Sector |
Financial Services |
Industry |
Insurance - Property & Casualty |
| Market Cap |
25,406,812,160 |
Cash |
3,898,912,000 |
| Debt |
3,103,180,032 |
Recommendation |
hold |
| RSI |
36.6 |
MACD |
-0.96 |
| Signal |
-0.69 |
Histogram |
-0.27 |
| Revenue Growth |
1.0% |
EPS Growth |
15.0% |
| Gross Margin |
44.0% |
ROE |
20.0% |
| Target Price |
69.53 |
Analysts |
17 |
|
|
-14.0
|
WSO
|
Watsco, Inc.
|
314.98
|
hold
|
2%
/
7%
|
8%
|
43.0
↑
|
2.22
|
-0.14
|
▼ |
| Sector |
Industrials |
Industry |
Industrial Distribution |
| Market Cap |
12,819,531,776 |
Cash |
464,188,992 |
| Debt |
535,268,992 |
Recommendation |
hold |
| RSI |
43.0 |
MACD |
-10.50 |
| Signal |
-12.72 |
Histogram |
2.22 |
| Revenue Growth |
2.0% |
EPS Growth |
-12.0% |
| Gross Margin |
28.0% |
ROE |
17.0% |
| Target Price |
378.70 |
Analysts |
10 |
|
|
-33.0
|
WVE
|
Wave Life Sciences, Inc.
|
4.97
|
strong_buy
|
-74%
/
0%
|
0%
|
38.6
↑
|
-0.02
|
-0.33
|
▼ |
| Sector |
Healthcare |
Industry |
Biotechnology |
| Market Cap |
993,122,816 |
Cash |
490,601,984 |
| Debt |
43,590,000 |
Recommendation |
strong_buy |
| RSI |
38.6 |
MACD |
-0.21 |
| Signal |
-0.19 |
Histogram |
-0.02 |
| Revenue Growth |
-74.0% |
EPS Growth |
N/A |
| Gross Margin |
-202.0% |
ROE |
-67.0% |
| Target Price |
19.06 |
Analysts |
16 |
|
|
0.0
|
WY
|
Weyerhaeuser Company
|
23.38
|
buy
|
-1%
/
7%
|
44%
|
38.6
↑
|
-0.17
|
0.00
|
▼ |
| Sector |
Real Estate |
Industry |
REIT - Specialty |
| Market Cap |
17,038,198,784 |
Cash |
527,000,000 |
| Debt |
5,448,999,936 |
Recommendation |
buy |
| RSI |
38.6 |
MACD |
-0.21 |
| Signal |
-0.04 |
Histogram |
-0.17 |
| Revenue Growth |
-1.0% |
EPS Growth |
87.0% |
| Gross Margin |
15.0% |
ROE |
5.0% |
| Target Price |
31.27 |
Analysts |
11 |
|
|
-1.0
|
XEL
|
Xcel Energy Inc.
|
75.89
|
strong_buy
|
-5%
/
15%
|
48%
|
38.2
↑
|
-0.22
|
-0.01
|
▼ |
| Sector |
Utilities |
Industry |
Utilities - Regulated Electric |
| Market Cap |
47,753,289,728 |
Cash |
2,018,000,000 |
| Debt |
41,650,999,296 |
Recommendation |
strong_buy |
| RSI |
38.2 |
MACD |
-0.68 |
| Signal |
-0.46 |
Histogram |
-0.22 |
| Revenue Growth |
-5.0% |
EPS Growth |
24.0% |
| Gross Margin |
47.0% |
ROE |
10.0% |
| Target Price |
91.76 |
Analysts |
17 |
|
|
5.0
|
XLP
|
State Street Consumer Staples S
|
85.25
|
|
N/A
/
N/A
|
75%
|
49.0
↑
|
-0.12
|
0.05
|
▼ |
| Sector |
|
Industry |
|
| Market Cap |
N/A |
Cash |
N/A |
| Debt |
N/A |
Recommendation |
|
| RSI |
49.0 |
MACD |
0.20 |
| Signal |
0.32 |
Histogram |
-0.12 |
| Revenue Growth |
N/A |
EPS Growth |
N/A |
| Gross Margin |
N/A |
ROE |
N/A |
| Target Price |
N/A |
Analysts |
N/A |
|